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ALM Appendicular lean mass 
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DXA Dual-energy x-ray absorptiometry 
DHA Docosahexaenoic acid 
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RANKL Receptor activator of nuclear factor κβ ligand 
RCT Randomized Clinical Trial 
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RDA Recommended Daily Allowance 
SD Standard deviation 
SMI Skeletal muscle index 
TUG Timed-up-and-go test 
UVB Ultraviolet radiation B 
VDR Vitamin D receptor 
WHO World Health Organization 
n3 PUFAs n3 polyunsaturated fatty acids 
1,25-(OH)2D 1,25-dihydroxyvitamin D (calcitriol) 
25-(OH)D 25-hydoxyvitamin D (calcidiol) 
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Abstract 
Background: The aging process involves decline of both muscle and bone mass. The 
loss of muscle mass is associated with decreased muscle strength and mobility, while 
loss of bone mass leads to osteoporosis and increased risk of fractures. This process 
maybe accelerated due to poor dietary quality, low energy intake and undernutrition. 
Fish is a good source of nutrients that are associated with preserving both muscle and 
bone mass. In particular, fish is contributing substantially to vitamin D intake.  
Overall aim: The overall aim of this PhD-project was to investigate dietary 
predictors of bone mineral density, risk of hip fractures, muscle strength and mobility 
in community-dwelling older persons.  
Specific aims: 
1. The aim was to summarize the available literature in a systematic literature 
search on randomized clinical trials investigating the effects of vitamin D 
supplementation (with or without calcium supplementation) on muscle 
strength and mobility in community-dwelling older persons, presented as a 
narrative systematic review and a formal meta-analysis on measures of muscle 
strength and mobility. 
2. The aim was to examine the association of fish intake with bone mineral 
density and risk of hip fractures in the Hordaland Health Study (HUSK), by 
conducting   
a) a cross sectional analysis of the association between fish intake and bone 
mineral density in middle - aged and older participants, and   
b) a prospective analysis of the association of baseline fish intake with the risk 
of hip fractures in the older cohort during a follow -up of ten years.  
3. The aim was to conduct a clinical observational study on weight change and 
mobility in community-dwelling hip fracture patients during the first two to 





1. The systematic review included 15 studies. In the majority of studies, no 
improvements in muscle strength or mobility were observed after 
administration of vitamin D with or without calcium supplementation. The 
quantitative meta-analysis did not reveal any clinically relevant effects of 
vitamin D supplementation neither on handgrip strength (seven studies) nor on 
the timed-up-and-go test (five studies). 
2. a) Cross-sectional analyses from the HUSK study showed an association between 
high fish intake and higher bone mineral density in older women, but not in middle-
aged women or in men.     
b) A low intake of fish was associated with increased risk of hip fracture in older 
men during a follow-up of ten years. This association was not evident in older 
women. 
3. Among community-dwelling hip fracture patients with normal cognitive 
function, age and weight loss were associated with insufficient mobility two 
months after the fracture.  
 
Conclusions: Vitamin D supplementation had no clinically relevant effect on measures of 
muscle strength and mobility. Fish intake did not have consistent effects on bone mineral 
density and risk of hip fractures. The findings of positive effects of fish intake in subgroups 
but not in the entire population have to be interpreted with care. Age and weight loss were 
the main determinants of mobility in patients after a hip fracture. In conclusion, 
maintenance of weight, muscle mass and bone mineral density are key issues for health of 
older persons. The results of the present investigations suggest that the there is a need for 
more studies regarding diet and health outcomes in community-dwelling older persons.  
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1.1 Aging – loss of muscle and bone mass 
1.1.1 Aging 
Ever since the early Greek and Roman history, aging has been a problem for 
humanity. The ancient Greeks, represented by Aristoteles (384 BC), actually 
“abhorred aging, since it represented corruption of their highly prized youthful vigor 
and was considered as a chronic, incurable, and progressive disease”. The widespread 
assumption was thus that old men should not engage in any activity because of their 
frailty. Cicero (44 BC), however, argued that: “it is our duty to resist old age, to 
compensate for its defects, to fight against it as we would fight a disease, to adopt a 
regimen of health, to practice moderate exercise; and to take just enough food and 
drink to restore our strength”. The Greek physician and philosopher Galen of 
Pergamon (129 AD) saw aging as a stage between illness and health. He emphasized 
the importance of nutrition and exercise for healthy aging (1). Today, the goal is still 
healthy aging, and the World Health Organization (WHO) (2) has defined healthy 
aging as: “the process of developing and maintaining the functional ability that 
enables wellbeing in older age”. The present thesis will focus on three aspects that are 
a part of aging: sarcopenia, osteoporosis, and hip fractures. The nutritional factors 
that may be important in preventing and managing these aspects will be outlined and 
discussed. 
There is no conclusive definition of an older person, but a cutoff point of 65 
years is often used. The average life expectancy has risen dramatically in the last few 
decades, owing both to a dramatic decrease in infant mortality in the developing 
countries and to better treatment of diseases associated with aging. In particular, there 
has been a marked increase in life expectancy above the age of 60. This means that an 
increasing number of people can expect to live to the age of 60 or longer, and more 
people will reach an age of 80 or older (2). The world’s population older than 65 
years is expected to double from 2010 to 2040, from about 506 million to 1.3 billion 
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(3). The same trend is evident in Norway, where the number of older persons (aged 
above 67) is anticipated to double over the next decade (4). In 2015, 125 million 
people worldwide were 80 or older, and the oldest age group is estimated to increase 
dramatically by 2050 (5). This growing elderly population will make increasing 
demands on health services. There is also an urgent need for measures to improve 
quality of life and to prevent conditions that are frequent in older persons.  
With increasing age there are several changes taking place in the body, 
occurring on molecular, cellular, and systemic levels (Table 1). The molecular and 
cellular changes are beyond the scope of this thesis and have been summarized 
elsewhere (6).  
 
Table 1: Physiological changes having an impact on the nutritional status and physical function in 
the course of aging (inspired by Table 9.1 in (7)).  
 
Organ or system Degenerative characteristics 
Skeletal muscle Muscle mass and function decline with advancing age (sarcopenia), owing to 
reduced muscle contractility and reduced levels of sex hormones. This leads to 
an increased risk of falls and fractures. 




Poor dental status may lead to difficulties with chewing food. 
Reduced saliva production may lead to difficulties with swallowing food and 
affects taste and smell. 
Reduced production of stomach acid affects the bioavailability of several 
nutrients, e.g. vitamin B12.  
In the small intestine, bacterial overgrowth may affect absorption of nutrients. 
The colon loses its motility, which may lead to constipation and diverticular 
disease. 
Immune system The skin barrier (passive immune system) and the cellular immune system 
become compromised with increasing age, which means an increased risk of 
infections and hospitalizations. 
Lungs Reduced number of pulmonary alveoli may lead to reduced exercise capacity. 
Kidneys A reduction in the number of nephrons may lead to increased blood pressure 
and problems with fluid and electrolyte balance. 
Brain Dementia and cognitive decline have a major impact on every aspect of life, 
including the nutritional status (e.g. remembering to eat or how to eat).   
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Aging is associated with changes in body composition and function. In particular, 
muscle mass, strength, and mobility are declining, a process that is known as 
sarcopenia. The decline in bone mass eventually leads to osteoporosis (low bone 
mineral density), a condition that increases the risk of fractures. In what follows, 
attention will be focused on these two conditions in addition to hip fractures, the most 
severe consequence of osteoporosis. 
 
1.1.2 Muscle mass and strength, physical function and sarcopenia 
The term “sarcopenia” was first used to describe the age-dependent decline in muscle 
mass by Rosenberg in 1989 (8). It is derived from the Greek sarx = flesh and       
penia = loss. Prior to 2011, sarcopenia was only defined as loss of muscle mass (9), 
but later it was redefined by the European Working Group on Sarcopenia in Older 
people (EWGSOP) (10) as “a syndrome characterized by progressive and generalized 
loss of skeletal muscle mass and strength with a risk of adverse outcomes such as 
physical disability, poor quality of life and death”. Sarcopenia is diagnosed on the 
basis of predefined diagnostic criteria. These are 1) a low muscle mass and 2) either 
low muscle strength or poor muscle performance. The methods used for measuring 
muscle mass, strength, and performance according to the EWGSOP are listed in 
Table 2. This means that the modern definition of sarcopenia includes not only loss 
of muscle mass, but also loss of strength. However, the definitions and the criteria 
still vary (10-12). In the US, for example, the definition formulated by the 
International Working Group on Sarcopenia (13): “the age-associated loss of skeletal 







Table 2: Methods for measuring muscle mass, strength, and performance according to EWGSOP. 
Modified after (10). 
Variable Method Clinical practice 
Muscle mass Computed tomography (CT) 
Magnetic resonance imaging (MRI) 
Dual energy X-ray absorptiometry (DXA) 
Bioelectrical impedance analysis (BIA) 





Muscle strength Hand grip strength 
Knee flexion/extension 
Peak expiratory flow 
Hand grip strength 
Physical performance Short Physical Performance Battery (SPPB) 
Usual gait speed 
Timed get-up-and-go test 
Stair climb power test 
SPPB 
Usual gait speed 
Get-up-and-go test 
 
In 2016, sarcopenia received its own diagnostic code, ICD10-CM code M62.84, 
which means that it is now recognized as an independent, geriatric condition. To 
satisfy this code, one has to measure muscle mass by dual energy X-ray 
absorptiometry (DXA), perform a 10-meter gait speed and/or a hand grip strength 
measurement, or use a simple, validated questionnaire called SARC-F using 
predefined cutoffs (14, 15). 
At present, screening for sarcopenia is not part of the everyday routine either 
in community-dwelling older persons or in the nursing homes or hospitals. The 
prevalence of sarcopenia is therefore unclear, but it is estimated to be 5-13% in 60-70 
age group, and 11-50% in persons over 80 (16). In a study using the definition 
proposed by EWGSOP (10), the prevalence was found to be 1-29% in community-
dwelling populations and 14-33 % in long-term care populations. In the only acute-
care hospital examined in the study, the prevalence was 10% (17).  
Muscle consists of numerous muscle fibers in addition to connective tissue, 
blood vessels, and nerves. The interior of muscle fibers consists of myofibrils, which 
in turn are made up of the proteins actin and myosin. Actin and myosin are essential 
in muscle contraction. In addition, in a section of myosin there is a site for binding 
ATP. Because of the large energy requirements involved in muscle contraction, 
muscle fibers have a rich supply of mitochondria generating ATP. The action 
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potential in muscle is triggered by a signal from the nerves in motor nerve fibers in 
the muscles. One motor neuron is connected to many muscle fibers, while each 
muscle fiber is connected to only one motor neuron. A motor unit is defined as one 
motor neuron with its connecting muscle fibers. Based on the rate of the muscle 
contraction, muscle fibers are divided into two categories: type I (slow-twitch) and 
type II (fast- twitch). Another division between the muscle fibers is based on their 
capacity for anaerobic or aerobic production of ATP: fibers that make ATP by 
oxidative phosphorylation are said to be oxidative, and fibers that are able to cover 
their energy needs by glycolysis are said to be glycolytic. The type-I fibers are slow- 
twitch, oxidative fibers, while the type-II fibers are divided into two subcategories: 
fast-twitch oxidative fibers (type IIa) and fast-twitch glycolytic fibers (IIb). After 
birth, the formation of new muscle cells is limited, but with growth the size of the 
muscle fibers increases, and therefore so does the muscle volume. Satellite cells are 
precursors of skeletal muscle cells that are found in mature muscle cells. Hence, there 
are possibilities for forming new muscle fibers. Satellite cells can also repair existing 
cells (18). 
The processes that lead to sarcopenia with aging are complex (Figure 1). With 
aging the muscle mass is reduced. This is due mainly to loss of fibers. It has been 
suggested that about 60 % of the lost fibers are the type-II fibers (19). Type-II fibers 
are the most important muscle fibers for preventing falls, due to the “fast” response 
that is necessary to prevent falling. Loss of the type-II fibers is one reason for the 
increased risk of falling in old age (20). Other changes include a reduction in the 
amount of satellite cells, which are important for muscle growth and repair (21). The 
composition of the muscle changes. In addition, the muscle fibers are infiltrated with 
fat and connective tissue (myosteatosis) (1), and there are fewer motor units in 
advanced age (22). Owing to the age-related increase in mutations in mtDNA, there is 
also a reduced synthesis of mitochondrial proteins and/or an increased production of 
abnormal proteins. Both these processes are associated with reduced oxidative 
capacity, and hence with slower recovery after exercise and reduced mitochondrial 
function (23).  
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Figure 1: Overview of the processes leading to sarcopenia. The (primary) age-related 
changes that occur include reduced levels of sex hormones, reduced neuromuscular integrity, 
reduced protein synthesis, and presence of low-grade chronic inflammation. All this is 
accompanied by increasing insulin resistance, increased muscle fat content and increased 
proteolysis. In addition, presence of acute or chronic disease can affect the development of 
sarcopenia (secondary).   
 
Several endocrine changes occur as a person ages, including a decrease in the levels 
of sex hormones (i.e. testosterone and estrogen), insulin, corticosteroids, and growth 
hormone/insulin-like growth factor 1. This may influence the protein metabolism in 
both the anabolic and the catabolic state (24). “Anabolic resistance” is a term used for 
the phenomenon in which the response of protein synthesis to intake of dietary 
protein is diminished (25). Other changes that occur include increased proteolysis, 
insulin resistance, and low-grade chronic inflammation. The development of 
sarcopenia is to some degree physiological, and only becomes pathological when it 
exceeds a certain degree. The risk factors that contribute to the development of 
sarcopenia include age, gender, low physical activity (26), inadequate nutritional 
intake (24), smoking (27) ), and presence of chronic diseases (13); these factors often 
occur in combination.  
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The serious consequences of sarcopenia are increased frailty including reduced 
mobility, increased morbidity, and mortality. The functional decline and disability in 
older persons is strongly correlated with sarcopenia (9, 11) these individuals are 
consequently at a higher risk of falling and hence suffering an injury or fracture (27). 
Other consequences include increased susceptibility to hospital infections (28). 
 
1.1.3 Bone mineral density and osteoporosis 
Osteoporosis, derived from the Greek osteon = bone and porosis = porosity, is a 
systemic skeletal disorder characterized by porous bones, loss of bone mass, and 
deterioration of the bone structure. It is a condition without any clinical signs or 
symptoms until a low-energy fracture (fall from standing height or less) makes its 
presence evident. Thus, osteoporosis may be diagnosed in the presence of a low-
energy fracture or as defined by the WHO (29, 30): it is present when the bone 
mineral density (BMD) is 2.5 standard deviations below that of a young, healthy 
adult, applying age and gender-specific cutoffs. BMD is measured predominantly by 
DXA, which has become the gold standard for BMD measurements (31). The BMD 
at the femoral neck is regarded as the best measure of osteoporosis and a predictor of 
the risk of low-energy fracture (32). The factors that contribute to the development of 
low BMD are the unmodifiable ones - age, female sex, ethnicity, and early 
menopause, but also some modifiable ones: smoking, high alcohol consumption, 
physical inactivity, weight loss, and low body mass index (BMI). Factors that are 
thought to be protective are e.g. use of estrogen therapy, physical activity, and some 
dietary constituents that will be outlined in detail later on (33).  
Owing to the scarcity of clinical symptoms before a fracture occurs the 
prevalence of osteoporosis is uncertain, but it is estimated that 200 million people 
worldwide suffer from this condition (34). Hip fractures are often used as an index of 
osteoporosis prevalence. There are geographic variations in the incidence (35), even 
within Europe (36). Since life expectancy differs between different countries, this 
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also affects the prevalence of osteoporosis because loss of bone mass becomes more 
pronounced with advancing age.  
Bone tissue is of two types, cortical and trabecular. Cortical bone has a 
structural function and forms the outer, hard layer of most bones. Trabecular bone has 
a metabolic function, comprising bone marrow production of red blood cells and 
bone cell precursors. Trabecular bone forms the interior of most bones, and consists 
of a sponge-like web of thin calcified trabeculae (37). Trabecular bone undergoes 
remodeling seven times faster than cortical bone, and hence the sites of trabecular 
bone, like wrists, the spine, and the hips are more susceptible to fractures. After 
reaching the peak bone mass in the third decade of life, the bone remodeling phase 
sets in (33), a constant cycle of bone resorption (by osteoclasts) and bone formation 
(by osteoblasts). Osteoblast activity is stimulated by 1,25-dihydroxyvitamin D    
(1,25-(OH)2D) (38). With increasing age, osteoclast activity tends to exceed the rate 
of re-mineralization, and therefore the bone mineral content and density begin to 
decline. Other factors that contribute to decreased bone mineralization are decreased 
vitamin D synthesis in the skin, decreased absorption of calcium, and low-grade 
systemic inflammation (39). One of the systemic factors that controls the bone 
modeling cycle is estrogen. Examination of cortical bones has demonstrated that bone 
loss is closely linked to estrogen deficiency. On the other hand, the loss of trabecular 
bone seems to be independent of estrogen depletion (40). Several mechanisms may 
be involved in the menopausal loss of bone mass. Reduced estrogen production 
increases the production of pro-inflammatory cytokines. Binding of the receptor for 
nuclear factor κβ ligand (RANKL) to receptor activator of nuclear factor κβ (RANK) 
is essential for osteoclast activity and differentiation, but the activity of RANKL 
increases postmenopausally, leading to an increased activity of osteoclasts without a 
corresponding increase in the activity of osteoblasts (41). This contributes to a net 
loss of bone mass. The menopause in women and the associated loss of endogenous 
estrogen has historically been proposed as the sole reason for the accelerated loss of 
BMD with age (42), but later this has been questioned (43). Estrogen therapy was at 
one time used as replacement during menopause, but its use is now less common 
owing to its suspected side effects. However, the positive effects on osteoporosis and 
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hip fracture have been emphasized (44). Bone resorption is also inhibited by 
testosterone. The testosterone levels in men tend to decrease with age, and men with 
testosterone deficiency are more often osteoporotic and have a more rapid bone loss 
compared with men having normal testosterone levels (45). However, this effect on 
the BMD seems not to be as dramatic as estrogen deficiency in women.  
Osteoporosis increases the risk of hip, wrist, or spine fractures, which in turn 
may lead to loss of physical function and independence in activities of daily life, to 
poor quality of life, and to increased mortality. In people who have already suffered a 
low-energy fracture, the risk of having a new fracture at any site is considerably 
increased (46, 47). The consequences of hip fractures will be described in details in 
the following section.  
 
1.1.4 Hip fractures 
The occurrence of a hip fracture is strongly correlated with low bone mineral density 
(48). However, injury due to low energy fall or trauma is a prerequisite for a fracture. 
The low BMD increases risk of a fracture caused by the fall. Established modifiable 
risk factors for hip fracture include low BMI, recent weight loss, low protein intake, 
low calcium intake, sarcopenia, vitamin D deficiency and smoking (49-52). Fractures 
of the hip can occur in several locations (Figure 2). Further outlining of fracture sites 
and surgical procedures is beyond the scope of this thesis.  
Worldwide, about 1.7 million people suffer from a hip fracture annually (34). 
Norway has the highest prevalence of hip fractures in the world, about 8,400 people 
having been hospitalized for this condition in 2015 (53). The mean age of the hip 
fracture patients in Norway in 2015 was 80 years, and about 70% of these patients are 
women. Within Norway itself there are large regional differences in the incidence of 
hip fractures (54). In many countries, including Norway, the population rates of hip 




Figure 2: Overview of the various types of hip fractures. Hip fractures are divided into 
two main categories: intracapsular (femoral neck) and extracapsular (trochanteric and 
subtrochanteric). Source: https://www.physio-pedia.com/File:Figure1_hip_fracture.jpeg 
This work has been released into the public domain by its author.  
 
Hip fractures present major problems both on the individual level and for the society. 
Hip fracture patients have impaired physical function and an increased risk of 
mortality, and they require more health services. Hip fractures are thus associated 
with increased health care expenditure (56), comprising the costs of hospitalization, 
surgery, rehabilitation in specialized nursing home facilities, and the need for long-
term home care or nursing home residency for those with reduced mobility and 
abilities in their daily life (57). It has been estimated that about half of the patients 
who had been community-dwelling prior to the fracture required long-term care in 
nursing homes or at home after the fracture (48). These patients are also at an 
increased risk of a second hip fracture. In a study from Norway (47), the estimated 
10-year risk of a second hip fracture was 15% in women and 10% in men. The 
mortality rates after hip fracture remain high (20-35%), and are positively associated 
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with pre- and postoperative delirium, dementia, anemia, catheter-related urinary tract 
infections, and pneumonia (58-60), residence in a nursing home, and the male sex  
(61, 62). 
Hip fracture has a major impact on physical functioning of the patient. Early 
recovery of mobility is decisive for the long-term prognosis (63, 64). It is estimated 
that about half of the patients who had been able to walk independently before the hip 
fracture required an aid or became non-ambulatory within one year after the fracture 
(63-65). Low muscle mass and low strength predict an impairment of mobility one 
year after the fracture (66). These results suggest that presence of sarcopenia has huge 
implications for recovery of physical function and independence after a fracture. 
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1.2 Vitamin D  
1.2.1 Dietary intake  
Vitamin D, or calciferol, comes in two different forms, ergocalciferol (D2) and 
cholecalciferol (D3,), which differ only in their side-chain structure (67). The main 
dietary source is cholecalciferol, as there are only a few dietary sources of 
ergocalciferol: yeast and mushrooms (68). The main dietary source of cholecalciferol 
is fish, primarily fatty fish. Other sources are eggs, liver, cod liver oil, and fortified 
foods (69). In Norway, fish and fish products account for about 40% and eggs for 
about 17 % of the vitamin D intake, while 34 % comes from fortified skimmed milk 
and margarine. Norwegians in general do not have an adequate intake of vitamin D, 
but taking into account the contribution from cod liver oil, the average intake is close 
to the recommended value (70).   
 
1.2.2 Skin synthesis 
Dermal synthesis is the major natural source of vitamin D (71). Previtamin D3 is 
synthesized non-enzymatically in skin from 7-dehydrocholesterol during exposure to 
ultraviolet B (UVB) light at wavelengths of 290-315 nm. Previtamin D3 undergoes a 
temperature-dependent rearrangement to form vitamin D3 (72). The season and the 
latitude (solar zenith angle) determine the availability of UVB light of the correct 
wavelength (73). In northern cities like Bergen (60° 23' 34.76" N), the sunlight 
available for skin synthesis is only present approximately from April to September 
(74). This means that during the fall and in wintertime Norwegians have to rely on 
vitamin D reserves built up during the summer or must ensure adequate vitamin D 
intake. The skin synthesis of vitamin D is affected by several factors. Besides the skin 
type and the use of sun blockers, aging has a major influence, since the synthesis 




In addition to the long-known parts played by vitamin D in calcium and phosphate 
metabolism, several functions of vitamin D in the body have recently been 
discovered. Because of the scope of this thesis, only functions related to bone 
metabolism and muscle strength are discussed further on.  
 The main function of vitamin D is maintaining calcium and phosphate 
homeostasis. The calcium plasma levels are maintained within a narrow range (76). 
In its hormonal form 1,25-(OH)2D, vitamin D maintains calcium and phosphate 
homeostasis by acting predominantly on three different organs: the intestine, kidneys, 
and bone (77). In the intestinal enterocytes, 1,25-(OH)2D engages in the active 
transport of calcium by binding to vitamin D receptors, which leads to the synthesis 
of calcium-binding proteins. This in turn regulates the transport of calcium across the 
cell membrane. Regulation of the renal production of 1,25-(OH)2D is mediated via 
receptors in the parathyroid gland, which sense if the calcium levels are low and 
therefore release parathyroid hormones (PTH) (78). The increased production of 
1,25-(OH)2D leads not only to increased absorption of calcium in the intestine, but 
also to resorption of calcium in the kidneys and bone (79). An increase in the calcium 
levels inhibits PTH-secretion, and cells in the thyroid gland begin to secrete 
calcitonin. Calcitonin both blocks the resorption of calcium from bone and suppresses 
the production of PTH. The calcium and phosphate homeostasis is closely linked 
together. An increase in phosphate levels stimulates secretion of PTH and suppresses 
formation of calcitonin (67). The increased PTH levels increase renal production of               
1,25-(OH)2D, which stimulates osteoblasts and osteocytes to produce fibroblast 
growth factor 23 (FGF23). The increased FGF23 and PTH levels reduce reabsorption 
of phosphate in the kidneys and thus lower the phosphate levels. Action of FGF23 in 
the proximal tubuli is dependent on a transmembrane protein known as Klotho. 
FGF23 creates a multiloop feedback system by decreasing PTH secretion and down-
regulation of 1α-hydroxylase and thus the 1,25-(OH)2D levels (80).  
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Vitamin D has many known functions other than maintaining calcium 
homeostasis. Muscle weakness in rickets was described by Glisson already in the 17th 
century (81). Muscle weakness is still considered a symptom in vitamin D deficiency 
(20, 82) and in older persons (83, 84). In patients with osteomalacia, myopathy has 
been observed as one of the symptoms, which is reversible by treatment with    
vitamin D (85). However, it is uncertain whether a mild deficiency or insufficiency of 
vitamin D has a significant effect on muscle strength. The role of vitamin D in muscle 
function is complex and not fully understood, but some of the possible mechanisms 
are outlined below. 
The non-genomic effect of vitamin D is the most investigated muscle property. 
Muscle contraction is dependent on 1,25-(OH)2D-stimulated phosphorylation of 
proteins which regulates CaATPase, a transport protein that transfers calcium ions 
into the sarcoplasmic reticulum. In addition, the genomic effects of vitamin D are 
exerted via the expression of the vitamin D receptor (VDR), a nuclear receptor with a 
high affinity to 1,25-(OH)2D which regulates protein synthesis by its action (86-88). 
There are several VDR genotypes, which appear to give rise to differences in muscle 
strength (89). There is also a decline in the expression of VDR with increasing age, 
which may play a role in the age-dependent muscle weakness (90). 
 
1.2.4 Vitamin D status   
The serum levels of 25-hydroxy vitamin D (25-(OH)D) are used as the proxy for the 
body’s vitamin D stores because of its stability and long half-life (67). The methods 
used for the determination of 25-(OH)D levels have traditionally been immunoassays, 
but are now increasingly replaced by LC-MS/MS methods, which are more specific 
and easier to standardize. There is no agreement on the optimal level of 25-(OH)D, 
but the Institute of Medicine (IOM) and other bodies have accepted > 50 nmol       
(67, 91). However, the Endocrine Society (92) refers to an optimized level of             
> 75 nmol/L. An overview is presented in Table 3.  
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Table 3: Overview of the serum 25-(OH)D level cutoffs used for classification of the vitamin D 
status by the Institute of Medicine (IOM) (67), Nordic Nutritional Recommendations (NNR5) (91) 
and The Endocrine Society (92).  
Vitamin D status IOM  NNR5  Endocrine Society 
  nmol/L  ng/ml  nmol/L  ng/ml  nmol/L  ng/ml 
Deficiency < 30  < 12  < 25 < 10 < 50  < 20  
Insufficiency 30 - < 50 12 - < 20 30 - < 50 12 - < 20 53-73 21-29 
Sufficiency ≥ 50  ≥ 20  ≥ 50 ≥ 20 ≥ 75 ≥ 30 
 
Deficiency of 25-(OH)D is widespread in Europe, and the seasonal variation of the 
serum 25-(OH)D levels, with lower levels in winter, contributes to the problem (93). 
During the months without any dermal synthesis, people have to rely on dietary 
intake. A recent study (94) has investigated the prevalence using standardized        
25-(OH)D values from national surveys in Europe. The conclusion was that            
25-(OH)D deficiency (< 30 nmol/L) is common, occurring in about 13% of children 
and adults in Europe, with insufficiency (25-(OH)D levels < 50 nmol/L), running at 
about 40%. 
 
1.2.5 Dietary recommendations 
In line with scientific developments and the application of the risk assessment 
framework, the dietary recommendations in many countries have been modified    
(95, 96). ). In 2011, the IOM proposed new Recommended Daily Allowance (RDA) 
(67). In this report, the RDA was 600 IU/day, which was assumed to ensure serum 
25-(OH)D levels higher than 50 nmol/L for 97.5% of the healthy population in the   
1-70 years age group. In line with the IOM report, in 2014 the RDA in the Nordic 
countries was raised from 200 to 400 IU (91). When the diet and the supplements are 
considered together, the Norwegian intake of vitamin D from dietary sources   
(mainly from fish and cod liver oil) is among the highest in Europe (97). The dietary 
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recommendations for vitamin D will probably change again as the gaps in our 
knowledge are filled with new insights. The present recommendations for the US, 
Europe, and the Nordic countries are listed in Table 4. The dietary recommendations 
are based solely on dietary intakes of vitamin D needed to achieve sufficient levels 
without any contribution from skin synthesis. 
 
Table 4: Recommended intake of vitamin D (µg) in the US (98), European Union (EFSA) (99), 












Infants  10 10 10 10 
Children, adults 
and older persons 
(> 1 year) 
15 
>70 years: 20 
15 20 
>65 years: 20 
10 
≥ 75 years: 20 
1 µg = 40 IU 
* The age groups are not always the same 
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1.3 Fish consumption 
1.3.1 Nutrient content 
Fish in general is an excellent source of protein, n3 polyunsaturated fatty acids        
(n3 PUFAs), vitamins, and minerals including iodine and selenium. However, the 
nutrient content of fish varies between species. A rough classification according to 
the overall fat content is useful for identifying fish with high vitamin D contents, 
although other classifications are also in use. Lean fish contains on average less than 
2 g fat per 100 g of fish fillet, and fatty fish contains more than 8 g of fat. Fatty fish 
like herring, mackerel, and salmon are good sources of vitamin D and n3 PUFAs 
(101), and are the main source of vitamin D when endogenous synthesis is low. The 
amounts of protein in fatty and in lean fish are about the same, about 15 to 20 g of 
protein per 100 g fish fillet (102). Liver from lean fish (cod) is the source of cod liver 
oil, which is extensively used in Norway as a supplement (it provides both vitamin D 
and n3 PUFAs).  
 
1.3.2 Dietary recommendations and intake 
Norway is among the countries with highest fish consumption in Europe, together 
with Spain and Portugal (103, 104); the other European countries consume much less 
fish (105, 106). Fish as a food group is explicitly mentioned in food-based dietary 
guidelines. In Norway, the recommended intake is 2-3 fish servings per week 
(corresponding to 300-400 g), of which 200 g should be fatty fish (107). Other 
countries also recommend consuming fish at least 1-2 times a week (108). The 
differences between the recommended amounts can be explained by differences in 
the evaluation of the health benefits of fish (109-112) and the risks of environmental 
pollutants contained in fish (113, 114). A detailed discussion of the health benefits of 
fish and n3 PUFAs is beyond the scope of this thesis, but can be found in (113-116). 
 Norway and Spain give the highest recommendations for fish consumption, 
which is in line with the high intakes of fish in these countries. With its long 
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coastline, Norway has a long tradition of eating fish, though again there are 
differences within the Norwegian population (70), with older people consuming more 
fish than the younger, women eating less fish than men, and people living along the 
coast eating more fish than those living inland (117, 118). However, despite the high 
average fish consumption, only 20% of the men and 25% of the women are 
consuming as much fish as recommended (70).   
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1.4 Dietary predictors of muscle mass, bone mineral density 
and risk of hip fractures 
Diet is a modifiable factor in the prevention of low muscle mass and low BMD. It is 
clearly necessary to distinguish between the role of diet in the primary and in 
secondary prevention of these conditions. In addition, although dietary factors are 
definitely associated with healthy aging and with the maintenance of muscle mass 
they cannot be considered in isolation from a healthy lifestyle that also includes 
physical activity, giving up smoking and weight maintenance (33, 119). However, 
because of the scope of the present thesis, only nutritional factors and only those 
related to fish consumption will be discussed here. 
 
1.4.1 Nutritional factors in loss of muscle mass, strength and physical 
funtion 
In addition to specific nutrients that have been investigated in relation to the 
maintenance of muscle mass and strength, the need for an adequate energy intake has 
been emphasized as the most important dietary measure (119). Adequate energy 
intake is required to ensure that dietary protein is utilized in muscle protein synthesis 
(24) rather than in gluconeogenesis, and to prevent the breakdown of muscle protein. 
Dietary protein is the most important nutrient concerning muscle mass and strength. 
However, the evaluation of protein intake in primary and secondary prevention of 
muscle mass and strength losses is complicated by the dependence of protein 
requirements on adequate energy intake, physical activity, and the health status. 
While the NNR5 (91) are directed at healthy older persons, and thus recommend    
15-20 E% of protein intake (equivalent to about 1.1 – 1.3 g/kg body weight (BW)), 
other scientific societies have focused on the role of protein in disease and have 
recommended higher protein intakes (16, 120).  
The evidence on dietary protein intake in primary prevention of muscle mass 
loss is derived mainly from observational cohort studies (121-125), and less from 
intervention studies using protein supplementation (126, 127). In the cohort studies, a 
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higher protein intake was associated with smaller loss of lean body mass (128), less 
pronounced frailty (129), higher hand-grip strength, and better physical function 
(121-125). Most of these studies were done on older persons below the age of 80, and 
one of the few studies with very old persons (age > 85 years) reported that an intake 
of less than 1 g protein/kg BW was negatively associated with muscle strength and 
performance, especially in women (130). Regarding secondary prevention, it seems 
that regaining muscle mass is even more difficult to achieve. For example, one well-
designed intervention study did not find any increase in muscle mass in older adults 
after 12 weeks of intervention with 40 g protein per day (131).    
Vitamin D has also attracted much interest in connection with muscle mass 
and function. Many older persons suffer from vitamin D deficiency (77) and this has 
been associated with reduced mobility, but not with muscle strength (132, 133). Low 
vitamin D status has also been associated with development of sarcopenia in the 
prospective Longitudinal Aging Study Amsterdam (134). Thus, there is evidence 
from observational studies that vitamin D status is associated with reduced muscle 
mass and mobility. Several RCTs were conducted to test whether vitamin D 
supplementation would improve physical function in older persons. A major outcome 
measure was the risk of falls, which is often used as a proxy for low muscle strength 
and function (135, 136), although the risk of falls are multifactorial (137). Results of 
these RCTs have been summarized in several meta-analyses (135, 138, 139). These 
were complicated by differences in the vitamin D supplementation strategies    
(doses, metabolites, routes of administration) and in the population studied 
(community-dwelling vs. institutionalized, vitamin D status at baseline). Thus, results 
are inconsistent and there are doubts whether vitamin D supplementation can reduce 
the risk of falls. Other outcomes of physical function in older persons have also been 
addressed in a number of RCTs, which again have been summarized in several meta-
analyses (140-145). Again, it is difficult to compare studies due to difference in the 
population included, the vitamin D supplementation strategies and the outcomes of 
physical function.  
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1.4.2 Nutritional factors associated with bone mineral density and the risk 
of hip fractures 
A possible role of diet in the development of osteoporosis has been discussed for 
more than 40 years, with numerous studies having been published on primary and 
secondary prevention of osteoporosis and hip fractures (33). In addition to single 
nutrients, the role of sufficient energy intake and of nutritional status has attracted 
particular attention. In primary prevention of osteoporosis, the nutrients in question 
include the total protein intake and the sources (146, 147), calcium (148), vitamin D 
(149), vitamin K (150, 151), and n3 PUFAs (152, 153). Since osteoporosis develops 
throughout a person's lifetime, in primary prevention the diet during childhood and 
adolescence is also of interest (33). 
  Since bones contain large amounts of protein, it seems reasonable to look at 
the protein intake as a beneficial nutrient in the prevention of osteoporosis and hip 
fracture. Historically, a high protein intake was thought to be unfavorable, as it would 
increase the urinary calcium excretion. However, recent studies have not found any 
adverse effects of a high protein diet, owing to compensatory increased intestinal 
calcium absorption that could most probably replace the urinary calcium losses (154). 
Much research has been aimed at identifying the protective effects of specific kinds 
of proteins (animal vs. plant, dairy and soy), but the evidence for beneficial effects of 
specific kinds of protein is spars (155-159). A high protein intake may have a 
favorable effect on BMD, especially in combination with adequate intakes of calcium 
and vitamin D (146, 158, 160), although this may not be translated into a reduced risk 
of fracture (146, 154). This absence of beneficial effects was attributed to the 
proportions of protein and calcium in the diet, a protective effect on the risk of hip 
fracture being only present with diets high in calcium and protein (161).  
The effects of vitamin D supplementation on bone health and on fractures with 
both intermediate and clinical outcomes have been investigated in numerous RCTs, 
even before the current hype concerning vitamin D. The overall results suggest that 
de effect of vitamin D (with or without calcium) is still uncertain in preventing 
fractures (primary or secondary prevention), including hip fractures (162-164), 
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though this does not preclude a part played by vitamin D in the life-long development 
process of osteoporosis (33). Indeed, a low vitamin D status has been associated with 
low bone mineral density (165), and an increased risk of hip fractures (149). 
The association between fish intake and BMD has been investigated in 
populations from the US, China, and Spain with mixed results (166-170). Overall, 
there is a trend toward a positive association between fish consumption and BMD 
(171). However, no association between fish consumption and BMD was found in a 
review of studies on dietary patterns that included fish consumption (172). As part of 
fish, n3 PUFAs have attracted much attention for their potentially anti-inflammatory 
properties and their proposed effect on bone metabolism (171, 173). However, the 
effect of n3 PUFA intake on the development of osteoporosis is still unclear, both 
from observational studies (166, 174) and from RCTs (175, 176). When clinical 
outcomes are considered, the association between fish intake and the risk of hip 
fractures is unclear (167, 177, 178). 
 
1.4.3 Nutritional status and hip fractures  
From many studies involving hip fracture patients, it is evident that these patients 
predominantly have a lower BMI than their peers of comparable age (179, 180). 
Further in-depth investigations have shown that these patients also have a low food 
intake and are frequently undernourished (50, 180-183). These observations may 
indicate that a low muscle mass already before the occurrence of the fracture is 
common, but few studies have been done on this point (66). Hip fracture patients 
have a hypermetabolic state that persists for several weeks after the fracture (184). It 
is therefore not surprising that weight loss is common after the fracture (185-188), 
although this has not been studied in any detail. Only one study was found that 
reported on the association between weight loss after the fracture (where weight 
measurements had been made) and functional outcomes (185).  
The literature search for the present thesis was finalized on June 11, 2018.  
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2.  Rationale for the present study 
With increasing life expectancy, healthy aging has become a focus of health research. 
Europe has experienced a period of wealth and abundant food supply for more than 
six decades, which has shifted the focus in nutrition research from undernutrition and 
nutritional deficiencies to the role of nutrition in prevention of chronic disease and 
maintenance of health also in old age. As older persons are a heterogeneous 
population group, we chose, in order to reduce heterogeneity, to focus on community-
dwelling older persons with normal1 cognitive status. We were specifically interested 
in the effect of vitamin D supplementation on muscle strength and mobility, and the 
association between fish intake, osteoporosis and hip fractures. In addition, we were 
interested in the effect of weight changes on mobility after a hip fracture. Different 
approaches were applied to study these, including a meta-analysis and a clinical 














1 Cognitive status was not formally tested. However, when ability to sign informed consent is taken as a proxy 
for normal cognitive status, it can be stated that all participants in the HUSK- cohort provided informed consent 
at inclusion, as well as the patients admitted for a hip fracture that participated in the clinical study. The meta-
analysis was based on RCTs that also require informed consent. 
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3. Study objectives 
Main objective 
The overall aim of the PhD-project was to investigate nutritional factors, with special 
attention to fish intake and vitamin D on age related changes in muscle and bone 
mass. The aim was to summerize the effect of vitamin D supplementation on muscle 
mass and strength. Further, it was the aim to investigate the association of fish intake 
with bone mineral density and the risk of hip fractures. Finally, we wanted to study 
the effect of weight changes on mobility with a follow up of two months after a hip 
fracture. The PhD-project consists of three parts (meta-analysis, data from a cohort 




To summarize the evidence whether vitamin D supplementation with or without 
additional calcium supplementation improved physical function and muscle strength 
in community-dwelling older persons (systematic review and meta-analysis of 
randomized clinical trials).  
 
Paper II: 
To investigate the association between total fish intake, lean and fatty fish intake and 






To investigated the association between total fish intake and the risk of future hip 
fracture in HUSK-participants born in 1925-27. 
 
Paper IV: 
To investigate the effect of energy intake and weight change on mobility and physical 
function in Norwegian hip fracture patients up to three months post fracture.  
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4. Subjects and methods 
4.1 Study population and design 
4.1.1 Paper I: Systematic review and meta-analysis 
Relevant studies were identified by a systematic search of current literature using 
PubMed, Embase, Medline, Web of Science and the Cochrane Library, followed by a 
manual search of the extracted articles and existing reviews. The clinical trial registry 
‘ClinicalTrials.gov’ was also searched for unpublished trials. The search covered the 
period up to April 13, 2016. The search terms are found in Appendix I 
(Supplementary material). The inclusion criteria are stated in Table 5. Only the 
outcomes comprising hand grip strength (HGS) and timed-up-and-go (TUG) were 
investigated in a sufficient number of studies to perform a quantitative meta-analysis, 
whereas other outcomes of muscle strength and mobility were only included in the 
systematic review. 
 
Table 5: The inclusion criteria for the systematic review and meta-analysis.  
Design Randomized controlled trial 
Participants Older persons > 65 years of age 
Humans 
Community-dwelling 
Intervention Vitamin D supplementation – all forms and all doses, with or 
without calcium supplements or dietary advice 
Comparator Low dose of vitamin D or vitamin D 
metabolites or placebo, with or without calcium supplement 
Outcome measures  
     Systematic review Measures of muscle strength and mobility 
     Meta-analysis Hand grip strength (HGS) 




Briefly, HGS is a method for measuring muscle strength. HGS was measured with a 
hand-held dynamometer (189-191). The average of 2-3 measurements are calculated 
(191). TUG is a method for testing the mobility of a person. Subjects are observed 
and timed from the instant they rise from an armchair (seat height 48 cm, arm height 
68 cm), walk 3 or 4 meters, navigate an obstacle on the floor, and return to a fully 
seated position in the chair. Each subject perform the test three times and the fastest 
of the three trials is finally recorded (192). A description of the other physical 
performance tests used in the studies that are included in the systematic review is 
described in Appendix I (Supplementary material)).   
 
4.1.2 Papers II and III: The Hordaland Health Study (HUSK) 
The Hordaland Health Study ’97-’99 (HUSK) was conducted during 1997-1999 as a 
collaboration between the National Health Screening Service, the University of 
Bergen and local health services ( https://husk-en.w.uib.no/ ). The main purposes of 
HUSK were to quantify the burden of potentially modifiable risk factors in the 
general population and to lay the ground for etiological studies of specific risk 
factors/conditions in relation to diseases of interest. In HUSK, all individuals living in 
Hordaland county and born during 1953-1957 (29,400) were invited. In addition, 
2,291 men and 2,558 women born during 1950-1951, and 1,868 men and 2,470 
women born in 1925-1927, who had previously participated in the Hordaland 
Homocysteine Study (193) were invited. Both the last two birth cohorts were used for 
the analysis in Paper II. In Paper III, only the older cohort was suitable for analysis 









The participants were given a 169-item semi-quantitative food frequency 
questionnaire (FFQ) at the day of the health examination that was filled out at home 
and returned by mail to the HUSK Project Center in Bergen, Norway (Appendix V). 
The FFQ was analyzed using the database “Kostberegningssystem” 
(Kostberegningssystem, version 3.2; University of Oslo, Norway).  
 
Bone mineral density  
The participants received an invitation to measure their BMD. About 5,377 
participants underwent a DXA measurement (One stationary, fan beam dual X-ray 
densitometer; Expert-XL, Lunar; Madison WI, software version 1.72 and 1.90). The 
left hip was scanned unless there was a history of surgery or fracture, and the 
procedure followed the manufacturers guide. DXA measurements were performed 
between May 11, 1998 and August 8, 2000 (194). These data were used in Paper II in 
a cross-sectional design. A comparison between the reference values of the 
manufacturer (Lunar) of the DXA and the HUSK population was performed and the 




The number of hip fractures that occurred between 1997-1999 and December 31, 
2009 were registered by electronically searching the records from the six hospitals 
serving Hordaland County for diagnosis codes that coded for hip fractures. The 
extraction process has previously been described (196, 197). Information on mortality 
was obtained from the Norwegian National Registry. The hip fracture data were used 
in Paper III.  
 
Other measurements  
All participants took part in a one-day visit at the HUSK Project Center where several 
health examinations were performed including blood sampling, height and weight 
measurements. More information can be found at http://husk-en.b.uib.no/ 
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4.1.3 Paper IV: Weight change and mobility after hip fracture 
Paper IV was a longitudinal observational study on hip fracture patients with a 
follow-up of three months. The patients were recruited from both Haukeland 
University Hospital and Haraldsplass Deacon Hospital (both located in Bergen) from 
February of 2014 until December of 2015. Anthropometric and functional 
measurements and 24-hour recall (24HR) were conducted at three visits for every 
patient, Visit 1 at the hospital (immediately after surgery), at Visit 2 at rehabilitation 
(2-3 weeks after discharge), and Visit 3 at home (2-3 months after the fracture). The 
inclusion criteria were age above 60 years, hospitalized for a first hip fracture, able to 
walk without aid, community-dwelling before the fracture and normal cognitive 
function (the cognitive function was not tested in the study, but was considered by a 
nurse at the hospital or at the rehabilitation unit). Trained clinical dieticians or 
nutritionists performed all anthropometric and bioelectrical impedance analysis 
(BIA).  
 
24-hour recall (24HR) 
To assess the food consumption of patients at all visits, 24HR was conducted, 
following the USDA interview guideline (198). Portion size was estimated using a 
booklet with four different portions shown or was estimated in household 
measurements or number of items consumed. Data was entered in the online dietary 
tool “Kostholdsplanleggeren’ (www.kostholdsplanleggeren.no) which is based on the 
official Norwegian food composition table and edited by the Norwegian Food Safety 






Bioelectrical impedance analysis (BIA) 
BIA is a tool for calculating fat-free mass and fat mass in a person by sending a weak 
electrical current through the body (199). BIA is inexpensive and can easily be used 
bedside in the clinic. However, BIA is sensitive to changes in electrolytes and body 
fluid. The method has been validated for healthy older men and women (200) and for 
hip fracture patients (201). Different formulas are used for the calculation of fat-free 
mass and appendicular lean mass (ALM) (the muscle mass at the legs and arms). In 
this study, the formula for calculation of skeletal muscle index (SMI) using the ALM 
by Kyle et al. (202) was applied: 
 
ALM (Kyle) = -4.2111 + (0.267 x height2)/resistance + 0.0095 x weight + 1.909 x sex 
-0.012 x age + 0.058 x reactance  
SMI= ALM/height2 
 
New mobility score (NMS) 
The New mobility score (NMS) was used to investigate mobility. The NMS is a self-
reported, composite score of the patient’s ability to get about the house, get out of the 
house, and go shopping alone, with an aid or not at all (Table 6). A cane, crutches, or 
a walker was regarded as an aid (203, 204). The NMS has been validated and are 









Table 6: The New mobility score (NMS) from Parker et al. (203) with scores from 0-9.  
Mobility No difficulty With an aid With help from 
another person 
Not at all 
Able to get about the house 3 2 1 0 
Able to get out of the house 3 2 1 0 
Able to go shopping 3 2 1 0 
 
 
Information from patient records 
Blood values for albumin, haemoglobin, 25-(OH)D, CRP and creatinine were 
collected from DIPS (Distributed Information and Patient System for hospitals), 
mainly measured one day prior to surgery. Remaining variables, such as length of 
stay at the hospital, type of surgery and other personal information such as presence 
of osteoporosis, disease history (including co-morbidities), medication, blood 
pressure, type of hip fracture, type of fall and smoking status was also collected from 






4.2 Statistical analyses 
4.2.1 Paper I: The systematic review and meta-analysis 
Other outcomes than TUG and HGS were reviewed narratively because of the low 
number of studies evaluating these outcomes. Only TUG and HGS were present in 
more than three studies and thereby suitable for a quantitative meta-analysis. We used 
RevMan, version 5.3 (Cochrane collaboration) (206) for the analysis, with the 
outcome being represented by Forrest plots. Weighted mean differences for vitamin 
D versus placebo/control were calculated by subtracting the mean of the outcome of 
interest at the end of the study from the mean at baseline. Standard deviations (SDs) 
of the differences were calculated using a formula provided by the Cochrane 
Handbook (207), applying correlation coefficients of 1.0 for the HGS and 0.8 for the 
TUG-test. Because significant heterogeneity was observed between studies with a 
fixed effect model, we finally applied a random effects model. Studies that included 
more than one intervention group (208) were treated by dividing the number of 
subjects in the control group by the number of comparisons at the same time as 
retaining the mean (SD) of the change according to the Cochrane Handbook (207). 
Subgroup analyses were conducted with predefined study characteristics: baseline 
vitamin D status, oral administration of the supplement, daily dose of vitamin D, 
placebo group, supplementation with vitamin D2 or D3, and advice on calcium 
supplementation to explore possible reasons for the observed heterogeneity (209, 
210). 
 
4.2.2 Papers II and III: The Hordaland Health Study (HUSK) 
In both Papers II and III, continuous variables were presented as means and SD, and 
categorical variables as percentages. Differences between sex and age were assessed 
using Mann-Whitney U test for continuous variables and Fischer’s exact test for 
categorical variables. In Papers II and III, fish intake was categorized into quartiles, 
calculated separately for each sex and age group. Differences in characteristics across 
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quartiles of total fish intake were analyzed using linear regression for continuous 
variables and logistic regression for dichotomous variables.  
In Paper II, the association of fish intake with BMD was analyzed both in sex-
specific quartiles of fish intake and fish intake as continuous variable. Multiple linear 
regression analyses were performed to assess the association between intake of either 
total, fatty or lean fish and BMD (by age group and sex) with adjustment for potential 
confounders. Due to missing values in confounders (1.3-6.2%), the multivariable 
analysis included 4,279 participants whereas the energy-adjusted model included 
4,656 participants. There were no non-consumer of total fish. The number of non-
consumers of lean and fatty fish was low, 405 (8.7 %) and 255 (5.5 %) respectively. 
The non-consumers were categorized in quartile one.  
In Paper III, fish intake was introduced in the analyses a) in four categories 
(based on sex-specific quartiles) and b) as a dichotomous variable (comparing the 
lower quartile, Q1, to the three upper quartiles (Q2 to Q4). To explore visually the 
association between fish intake and risk of hip fracture we used Cox proportional 
hazards regression model fitting fish intake using restricted cubic splines with three 
knots. Cox proportional hazards regression models with death as competing risk were 
used to estimate the risk of hip fractures across fish intake quartiles. The results are 
presented as hazard ratios (HRs) and 95% confidence interval (CI). Models were 
adjusted for sex, BMI, plasma concentration of cotinine ≥85 nmol/L (a marker for 
recent nicotine exposure (211)), physical activity and energy intake. Further 
adjustment for intake of vegetables, fruit, dairy or meat, vitamin D and calcium intake 
or estrogen therapy (in women) did not materially change the association. In addition 
to overall analyses, we also conducted sex-specific analyses.  
Statistical software SPSS for Windows version 25 (IBM, NY, USA) and Stata 
Statistical Software (Release 15.0, College Station, Texas, USA: Stata Corp LLC) 
were used and a two-sided p-value <0.05 was considered statistically significant. 
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4.2.3 Paper IV: Weight change and mobility after hip fracture 
At baseline, characteristics of men and women were compared using Mann Whitney 
U test and Chi squared test. We also compared age and sex distribution among the 
two participating hospitals and weight according to whether it was self-reported or 
measured. Weight, dietary intake and other study outcomes were compared between 
Visits 1 and 2 by the Wilcoxon rank sum test for related samples. The same tests 
were used to compare Visits 1 and 3. The NMS at Visit 3 was used in a logistic 
regression analysis as dichotomous outcome variable (NMS > 5 reflecting sufficient 
mobility, NMS ≤ 5 reflecting impaired mobility). Age was used as explaining 
variable in all models, and only one additional explaining variable was used 
concurrently. Statistical software SPSS for Windows version 25 (IBM, NY, USA) 









Paper I: The systematic review and meta-analysis 
All studies included in the systematic review and meta-analysis were performed 
according to local ethical standards and the declaration of Helsinki.  
 
Papers II and III: The Hordaland Health Study (HUSK)  
The HUSK study was performed in accordance with the Declaration of Helsinki. All 
participants provided written informed consent. The Data Inspectorate and the 
Regional Committee for Medical Research Ethics (REC number: 2009/825) approved 
the study protocol. HUSK is registered in ClinicalTrials.gov (Clinical trial number: 
NCT03013725).  
 
Paper IV: Weight change and mobility after hip fracture  
The study was performed according to the Declaration of Helsinki. All participants 
provided written informed consent. The Regional Committee for Medical Research 




5.1 Paper 1: Systematic review and meta-analysis 
5.1.1 Main results 
Out of 2,408 publications obtained by systematic literature search in available 
databases, 15 articles were suitable for inclusion in the systematic review by our 
predefined inclusion criteria (see Table 5). From the systematic review, the majority 
of studies observed no improvement in muscle strength or mobility after 
administration of vitamin D with or without calcium supplements in community-
dwelling older persons with age above 65. There were many different methods for 
measuring muscle strength and physical function in these publications. Only the 
outcomes HGS and TUG test were present in a sufficient number of articles to 
perform a meta-analysis. Thus, for the outcome HGS, seven studies were available, 
and for the outcome TUG five studies were available. In the meta-analysis, we 
observed a non-significant change in HGS [0.2 kg (95% confidence interval = -0.3 to 
0.7 kg)] and a small, significant improvement in the TUG test [0.3 s (95% confidence 
interval: 0.1 to 0.5 s)] after vitamin D supplementation (for clarification, see attached 
Errata). The meta-analyses showed a high degree of heterogeneity between the 
studies.  
A new literature search using the same search terms as in Paper I was 
performed on June, 11 2018 to check for new publications. Two additional studies 
were suitable for inclusion in the systematic review (212, 213). A narrative review of 
the publications are available in the next section. Searching ClinicalTrial.gov 
revealed several studies that had completed their study period or were recruiting; 





5.1.2 Narrative review of additional clinical studies  
Monthly High-Dose Vitamin D Treatment to Prevent Functional Decline 
In the study by Bischoff-Ferrari et al. (212), 200 community-dwelling, Swiss men 
and women (67.0 %) with a prior fall were participating. Average age was 78 years. 
Method for measuring 25-(OH)D was high-performance liquid chromatography– 
tandem mass spectrometry. The mean baseline serum concentration of 25-(OH)D was 
18 to 21 ng/mL (45 to 51 nmol/L) depending on treatment group. About 58% of the 
participants were defined as vitamin D deficient at baseline. The study design was a 
double-blinded RCT. A low dose of vitamin D was used as control instead of 
placebo. Participants were excluded if they continued to use calcium 
supplementation. Calcium supplements were not provided as part of the study 
protocol, and dietary calcium was not assessed. The season for blood withdrawal was 
stated, but the latitude of the study center was not provided. BMI as a possible 
covariate for vitamin D status was provided at baseline. The dropout rate was 
provided as a flowchart. Compliance was 94 to 98 %. Both D3 and calcifediol were 
used as vitamin D supplementation and provided in oral bolus doses of 24,000 IU 
D3/month (control), 60,000 IU D3/month, and 24,000 IU D3/month plus 300 µg 
calcifediol/month. Overall, the quality of the study was sufficient. A CONSORT 
checklist is presented in Appendix VI.  
The primary outcome of the study was the Short Physical Performance Battery. 
They also measured HGS, but with another device (Martin Vigorimeter) than the 
RCTs included in the meta-analysis in Paper I, and therefore not suitable for 
inclusion. The overall conclusion of the study was that none of the vitamin D 
supplement strategies was beneficial for the functional decline or prevention of falls 







Alfacalcidiol and muscle strength 
In the study by Setiati et al. (213), 95 older Indonesian women (age ≥ 60 years) with 
HGS ≤ 22 kg were participants. The median age was 70 years in both the placebo and 
intervention group. Serum 25-(OH)D was measured at baseline and during the study 
period, but the laboratory method used was not reported. The mean baseline serum 
concentration of 25-(OH)D was 37.5 ng/mL (94 nmol/L) in the placebo and 42.0 
ng/mL (105 nmol/L) in the intervention group. The study design was a double-
blinded RCT. The participants in both groups were provided 500 mg calcium per day 
and were not allowed to consume additional vitamin D or calcium supplementation. 
The season for blood withdrawal was not stated and neither was the latitude of the 
study center. BMI as a possible covariate for vitamin D status was provided at 
baseline. The dropout rate was provided as a flowchart; one participant from the 
treatment group and six participants from the placebo group withdrew from the study. 
The method for minimizing lack of compliance was addressed, but the actual 
compliance was not reported. A vitamin D metabolite, 0.5 µg alfacalcidiol/day, was 
the intervention chosen. The supplements were provided in sealed plastic packages 
for one month at the time. The duration of the study was 90 days. Overall, the quality 
of the study was sufficient. CONSORT checklist for the study is presented in 
Appendix VII.  
The primary outcome of the study was HGS measured by handgrip 
dynamometer and 3 m TUG test. Both the outcomes would therefore be suitable for 
inclusion in the meta-analysis performed in Paper I. The overall conclusion of the 
study was that a daily supplement of 0.5 µg alfacalcidiol and 500 mg calcium 




5.2 Paper II: Fish consumption and bone mineral density 
5.2.1 Main results 
Of the total HUSK cohort, 4,656 participants were examined by DXA-measurements 
and answered an FFQ. The mean (SD) total fish intake was 33 (18) g/1000 kcal and 
was primarily lean fish. Older women had significantly lower BMD than older men 
and middle-aged men and women. In older women, total and lean fish intake         
(per 50 g/1000kcal increase) was significantly and positively associated with BMD, 
even after multivariable adjustments (β-coefficient 0.018, p = 0.017 for total fish 
intake and 0.026, p = 0.02 for lean fish intake).  
 
5.3 Paper III: Fish consumption and hip fracture risk 
5.3.1 Main results 
Out of 3,327 eligible participants (age 71-74 years), information regarding food 
intake and hip fractures were available for 2,865 (86%). Mean (SD) follow-up time 
was 9.6 years (2.7). The number of hip fractures was 226 (7.9 %), 72 (5.5 %) in men 
and 154 (9.9%) in women. Mean (SD) total fish intake was 48 (25) g/1000 kcal in the 
entire cohort, with higher consumption in men (51 (25) g /1000 kcal) than in women 
(45 (25) g/1000 kcal). Both in men and women, lean fish was the main fish type 
consumed, followed by fatty fish and processed fish. The association between fish 
intake and risk of hip fracture was not linear and displayed a threshold, with low 
intake of fish being associated with increased risk of hip fracture in men      
(HR=1.84, 95% CI 1.10, 3.08). 
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5.3.2 Additional results 
We performed competing risk analysis for fish intake as a continuous variable, in sex-
specific quartiles, and for the lowest versus the upper three quartiles of fish intake. 
Death was the competing event. The results are presented in Tables 7-9. The results 
were not substantially different from the Cox proportional hazards regression 
presented in Paper III, and therefore not provided as tables in the paper.  
 
 
Table 7: Cox proportional hazards regression with death as competing event of risk of hip fracture 
according to continuous baseline fish intake among the total cohort of men (n=1,1315) and women 
(n=1,58) in the Hordaland Health Study followed from inclusion in 1997-99 (age 71-74 years) until 




Adjusted for sex, BMI (cont.), plasma cotinine above 85 nmol/L (yes/no), physical activity (none, low, 












 SHR 95% CI p-value 
Total fish, g/1000 kcal 1.00 (0.99, 1.00) 0.400 
Lean fish, g/1000 kcal 1.00 (0.99, 1.01) 0.424 
Fatty fish,  g/1000 kcal 1.00 (0.99, 1.02) 0.605 
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Table 8: Cox proportional hazards regression with death as competing event of risk of hip fracture 
according to sex-specific quartiles of baseline fish intake among the total cohort, men (n=1,1315) and 
women (n=1,58) in the Hordaland Health Study followed from inclusion in 1997-99 (age 71-74 








Adjusted for sex, BMI (cont.), plasma cotinine above 85 nmol/L (yes/no), physical activity (none, low, 





Table 9: Cox proportional hazards regression with death as competing event of risk of hip fracture 
comparing Q1 with Q2-Q4 of baseline fish intake for the total cohort (men, n=1,1315 and women, 
n=1,58) in the Hordaland Health Study followed from inclusion in 1997-99 (age 71-74 years) until 





Adjusted for sex, BMI (cont.), plasma cotinine above 85 nmol/L (yes/no), physical activity (none, low, 
moderate, high) and energy intake (cont.) 
 Total fish,  
g/1000 kcal 
HR 95% CI P 
Total cohort Q2-Q4 1.00 (ref)   
 Q1 0.74 (0.54, 0.99) 0.049 
Men Q2-Q4 1.00 (ref)   
 Q1 0.56 (0.34, 0.95) 0.030 
Women Q2-Q4 1.00 (ref)   
 Q1 0.84 (0.57, 1.22) 0.360 
Total fish, 
g/1000 kcal   
SHR 95% CI p for 
trend 
Q1 1.00 (ref)   
Q2 0.76 (0.51, 1.12)  
Q3 0.82 (0.56, 1.19)  
Q4 0.64 (0.42, 0.96) 0.163 
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5.4 Paper IV: Weight change and mobility after hip fracture 
5.4.1 Main results 
In the hospital, 64 patients (48 women, 16 men) agreed to participate in the study and 
either reported their weight (n = 30) or had their weight measured (n = 34). Half of 
the patients were older than 80 years. Median weight in women was 58.5 kg       
(IQR: 50.2, 67.8) and in men 70.0 kg (IQR: 60.8, 88.1) (p<0.05). Dietary intake in the 
hospital was assessed by 24HR after the surgery (median no of days after surgery: 3 
(range 1-10) and a median energy intake of 1314 kcal/d (IQR: 936, 1620) was 
reported, with significant differences between men and women.  
The main finding of this observation study in hip fracture patients was that, 
besides older age, even a moderate weight loss in hip fracture patients was associated 
with reduced mobility (NMS ≤ 5) at two months after the fracture. This association 
was independent of other factors including sex, energy or protein intake, and major 
comorbidities (cardiovascular disease, diabetes mellitus, hypertension, chronic 
obstructive pulmonary disease). However, observed weight change was less than 5% 
in most patients, and would therefore not be considered as a significant weight loss 




The effects of nutritional factors on age-related physiological changes including loss 
of muscle mass, strength, physical function, and bone mass, with the serious 
consequence of a hip fracture have been the overall theme of this thesis. In 
community-dwelling older persons, we found that vitamin D supplementation was 
not clinically relevant for muscle strength and mobility. Fish intake was positively 
associated with bone mineral density, but only in older women and not in the other 
groups. In older men, however, we observed an increased risk of hip fractures where 
the consumption of fish had been low. Thus, the association of fish intake with bone 
mineral density did not translate into a reduced risk of hip fractures in the group of 
older women. In the clinical study, it was observed that about ¾ of the hip fracture 
patients lost weight during follow-up, and 2 months after the fracture weight loss and 
age were negatively associated with mobility.  
 
6.1 Methodological considerations 
6.1.1 Study design and data analysis 
In the hierarchy of research designs, meta-analyses of RCTs are regarded as the 
design providing the best evidence. However, there are many potential pitfalls 
associated with meta-analyses, ranging from completeness of the trawl through the 
literature to evaluation of individual studies and the statistical analysis. In the present 
case, we performed a systematic search of the literature in relevant medical databases, 
including the trial registry ‘ClinicalTrials.gov’, which allows identification of 
ongoing and therefore still unpublished trials. Relevant articles were also searched 
manually. Predefined inclusion and exclusion criteria and predefined search terms 
were used. We included only those RCTs in which vitamin D supplementation had 
been used. However, the vitamin D was provided in various forms, as vitamin D2 and 
D3 or as active metabolites such as 1,25-(OH)2D. In most studies there was also 
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concurrent supplementation of calcium in a variety of doses. In addition, the vitamin 
D supplementation was provided in daily, weekly, or monthly doses, and the route of 
administration was either oral or intramuscular. The duration of the studies also 
varied considerably. The outcomes of the included studies showed considerable 
differences, which made comparisons difficult and precluded a formal meta-analysis 
of outcomes other than TUG and HGS. The number of studies included in the meta-
analysis was relatively small, and the heterogeneity of the studies was substantial.  
The main strength of the meta-analysis design is the ability to pool small 
studies together. However, a meta-analysis based solely on small-scale studies has a 
lower capacity for critical bias evaluation, since the statistical tests require a large 
number of studies. Owing to the small number of studies included in the meta-
analysis, it was difficult to perform a subgroup analysis that could explain the high 
degree of heterogeneity. The characteristics of baseline vitamin D status, oral 
administration of the supplement, the daily dose of vitamin D, the placebo group, 
supplementation with vitamin D2 or D3 or with active metabolites, and advice on 
calcium supplementation were all explored, but could not explain the heterogeneity. 
It would have been interesting to investigate the data using meta-regression, but this 
could not be done because of the small number of studies. Publication bias and 
heterogeneity could also have been explored using funnel plots (215), but again the 
lack of statistical power was an issue. This means that the results must be presented 
with circumspection (215).  
In addition to the quantitative meta-analysis, we also conducted a narrative 
systematic review on the available evidence concerning the effects of vitamin D 
supplementation on muscle strength and mobility. After Paper I had been published, 
we identified two more studies that were relevant and that had been published 
recently (212, 213). These were high-quality studies of adequate scale, and they are 
described in the Results section. One of them (212) further confirmed the findings of 
the systematic review that vitamin D supplementation with or without calcium has 
little or no effect on muscle strength measurements. The other study (213) found a 
significant improvement in both muscle strength and mobility after supplementation 
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with the vitamin D metabolite α-calcidiol and with calcium. In comparison with the 
studies included in Paper I, these two studies differed in the vitamin D 
supplementation provided, in modes of administration (daily doses and bolus), in the 
outcome measures, and in duration. In one of them (212) over half of the participants 
were vitamin D- deficient, whereas in the other study (213) the number of vitamin D- 
deficient women was not stated. 
In contrast to the positive findings of the new publication (213) in the majority 
of studies there was no evidence of any improvement in muscle strength or mobility 
after vitamin D supplementation. This could have been due to a number of reasons, 
for example because improvement of muscle function is more difficult at more 
advanced age and would require longer study periods. More promising effects has 
been observed in studies using interventions that combine nutritional measures and 
exercise (17). More standardized measurement of the outcome measures is highly 
recommended (216).  
In Papers II and III we used data from the HUSK-study, in which the baseline 
examinations were performed in 1997-1999. Information on diet as the exposure 
variable was self-reported, with a validated FFQ (217, 218). Information on the 
outcome BMD was obtained by the DXA method, which is considered to be the gold 
standard (31). The outcome hip fracture was determined by an electronic search of 
patients’ hospital records (196, 197, 219), ensuring high ascertainment of cases. 
Paper II analyzed cross-sectional data, while prospective data were used in Paper III. 
However, observational studies are not suitable for establishing causality.  
In Papers II and III, the analyses were adjusted for a number of variables that 
were either measured or self-reported. Energy intake, alcohol consumption, and 
physical activity were all self-reported, and are thus subject to different biases. Recall 
of physical activity, diet, and alcohol consumption is difficult. BMI was calculated 
from measured height and weight, and is therefore a precise measure. Determination 
of plasma cotinine is more objective than self-reported smoking habits, as it measures 
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current tobacco use with good correlation, and even includes exposure to passive 
smoking (211).  
In Paper IV a longitudinal design was applied. The hip fracture patients were 
followed up for approximately 2-3 months after the fracture. The primary endpoint 
was mobility at this time-point. The longitudinal design was suitable for tracking 
potential changes in energy intake and weight changes over time (220). In the 
immediate postoperative period the patients are in a catabolic state, and their basal 
energy needs are therefore increased (184), increasing the risk of a loss of weight. 
All dietary interviews and anthropometric measurements were carried out 
directly, not using a proxy. Weight measurements were difficult to perform in the 
hospital shortly after surgery, as the patients were tired or in pain. No bed-scales or 
chair-scales were available, so that self-reported weights had to be used in about half 
of the cases. Mobility was assessed with the aid of the NMS, an easy and valid 
instrument (204). This method was chosen as it could be applied in the patients' 
homes and considered their physical limitations. In the logistic regression, age was 
used as the explaining variable in all models, and only one additional explaining 
variable was used concurrently because of the small number of patients.  
 
6.1.2 Study population 
In the present thesis the focus was solely on community-dwelling adults and older 
persons. By excluding nursing home residents it could be assumed that the 
comorbidity burden in the population would be reduced. However, even in 
community-dwelling older persons there is a high prevalence of comorbidity, which 
was also observed in the different populations investigated in the present thesis. This 
is evident by use of medications in the middle-aged HUSK participants (221), 
comorbidities in the older cohort (222), and the comorbidity burden in the clinical hip 
fracture study (data not shown). In addition, in many countries home care services 
allow older persons to live longer independently despite their diminished health 
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status. The reasons for focusing on this group of older persons were different in the 
different studies included in this thesis. In Paper I, the focus on community-dwelling 
older persons was in contrast to other studies that combined nursing home residents 
or hospitalized and community-dwelling older persons (140-145). Although this 
reduced heterogeneity among the participants, it did not reduce heterogeneity 
between the studies.  
In HUSK, the participants were community-dwelling at baseline, but there was 
no information on whether they had moved into an institution after the baseline 
examination. In population-based epidemiologic studies the problem is that not all of 
those who are selected for inclusion are willing to take part. In a number of studies 
(223, 224), it was found that the socio-economic status and personal traits determine 
whether a person will be willing to participate. People with lower education and 
lower socio-economic status are as a rule less likely to participate, which impairs 
generalizability. Similar trends were observed in HUSK. Some information on the 
level of education and socio-economic status is available for the non-participants. The 
average income and the highest degree of education were higher among the 
participants than in the non- participants, and this applied to both men and women. In 
addition, significantly more of the non-participants were receiving social security 
benefits (194).  
In HUSK, the participants were included as part of two birth cohorts with a 
small age range (40-43 and 70-74 years old), including both men and women. This is 
a difference from other studies on BMD and the risk of hip fracture, which were 
usually performed in older persons with a wider age range (age above 65 years)   
(166, 167) or in postmenopausal women (168, 170). Thus, age was not a factor to 
adjust for in the present analyses. BMD was stratified specifically for age and gender 
because of the loss of BMD over time. Though the study was cross-sectional, it was 
evident that BMD was much lower in the older cohorts than in the middle-aged, and 
this was particularly evident in women.  
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The hip fracture study also included community-dwelling older persons, but  
(as in the other studies) it excluded patients with dementia or cognitive decline. More 
specifically, all patients unable to give their informed consent were excluded as a 
proxy for dementia. By choosing to include only community-dwelling persons 
without dementia, the “healthiest” of the hip fracture group were the target and those 
with a high comorbidity burden were excluded (225). Still, both the recruitment and 
the rate of dropouts from follow-up presented great difficulties. This is similar to the 
situation in other studies on older persons and patients (66, 131, 185, 226), and it may 
have compromised both external and internal validity.  
 
6.1.3 Methods of dietary intake assessment 
As stated by the late Professor George Beaton (227): “There will always be errors in 
dietary assessments. The problem is to understand, estimate, and make use of the 
error structure during analysis”. This is the very essence of dealing with dietary 
intake data. Both the FFQ and the 24HR were used in the present thesis. These 
methods are not directly comparable and they lead to different results. 
 
Food frequency questionnaire (FFQ) 
The FFQ used in HUSK was a 169-item semi-quantitative questionnaire. The 
strengths of the FFQ are that it is easy to fill out for the participants, it is an easy and 
cost-efficient way of assessing dietary habits in large cohorts, and it reflects habitual 
diets. Its limitations include estimation of the portion sizes and the non-reporting of 
food items that are not listed. Both of these limitations contribute to underreporting 
(228). However, it has been shown that the energy intake increases with increasing 
number of items to choose from, and that it would be difficult to obtain correct 
estimates from foods consumed only in specific seasons. Nevertheless, HUSK used a 
169-item FFQ, which provided many food items to choose from, was conducted all 
year round, and the large number of participants may have offset this problem.  
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Intake of fish was the exposure variable explored in both Papers II and III. 
Knowledge of the fish intake in the general Norwegian population in 1997-1999 
(when HUSK was carried out) can be compared with the national dietary survey 
NORKOST2 (117), which also used an FFQ, although a different. The fish intake in 
HUSK is actually overall comparable with the fish intake in NORKOST2, which may 
support the external validity of the HUSK data. The FFQ listed food items in a way 
that was adapted to Norwegian consumption habits. This is illustrated by the 
Norwegian habit of consuming fish as spread and the use of several fish products 
eaten for dinner, which is very specific for the Norwegian diet (229). 
A small, but significant positive effect of fish consumption on BMD was 
observed in older women in Paper II. In Paper III a low fish intake was associated 
with an increased risk of hip fracture, especially in older men. The measurement 
errors, which often occur in FFQ data, may cause associations to be under- or 
overestimated. This is in addition to occurrence of other residual confounding that is 
often found e.g. in a regression model (228). In the present dietary data, several 
measures were taken to reduce the errors of the dietary intake determinations. In the 
first place, the questionnaire was compared against another method of dietary intake 
assessment (weighted dietary records) (217) and against a biomarker (fatty acid 
composition in serum phospholipids and in adipose tissue) (217, 218, 230). The FFQ 
has been validated specifically for fish and n3 PUFAs intake (217, 218). The overall 
correlation coefficients between docosahexaenoic acid (DHA) intake according to the 
FFQ and the DHA content of adipose tissue and serum phospholipids were both 0.49, 
which is in line with the results of several similar investigations (231-233). Secondly, 
the analysis in Papers II and III was energy-adjusted (234), which may improve the 
risk estimate of low BMD and the risk of hip fractures (228). Despite these measures, 
misclassification cannot be ruled out. The energy intakes in persons after hip fracture 
observed during follow-up and in persons without fracture were similar, despite 
different mean BMI (data not shown). This may indicate underreporting, especially in 




24-hour recall (24HR) 
In Paper IV, the dietary intake was assessed by the 24HR method. The strengths of 
this method are that it is easy to perform both for the respondent and for a trained 
interviewer; it is quick, it gives more detailed information on the foods consumed 
than an FFQ, it is culturally neutral, and it tends to be less prone to biases compared 
with the FFQ (236). The primary limitations of the 24HR are problems with 
remembering the food intake over last 24 hours and quantification of the food eaten 
(228). This makes the 24HR prone to underreporting that also may have been relevant 
in the present study. Underreporting by the 24HR can be reduced by using 
standardized methods, e.g. the multiple pass method that has also been used in the 
present study (198, 237). Severalfold repetition of the 24HR has been shown to give a 
better estimate of both energy intake and nutrients (238). However, a Swedish study 
that investigated predictors of underreporting using the multiple pass method and 
repetitions of the 24HR still reported that BMI, old age and smoking were the main 
predictors of underreporting (239). We have reason to believe that underreporting 
occurred also in the present study. At visit 3, the median ratio between calculated 
energy intake and resting metabolic rate was 1.3, which is rather low. Furthermore, it 
can be speculated that if the patients included had consumed only the reported 
amounts of energy, the weight loss must have been even more pronounced than the 
observed one. However, the hip fracture patients included in this study would not 
have been able to complete an FFQ or dietary records, at least not during 




6.2 Discussion of general aspects of the thesis  
6.2.1 Food and supplements 
The present thesis investigated both the effects of dietary supplements and fish as 
food group on various health outcomes. In intervention studies, for both scientific and 
practical reasons it is much easier to conduct a study with dietary supplements than 
with actual food. Issues may include blinding of the investigators and the study 
participants, standardization, bioavailability, taste preferences, daily life suitability, 
and energy compensation. This may be why there are many more intervention studies 
with supplements than with specific food items. This is illustrated by the low number 
of RCTs using fish as interventions with intermediate outcomes (101, 218). However, 
even in supplementation trials there are problems, concerning the duration of 
supplementation in comparison with lifelong consumption of a food item, the doses, 
and in the case of vitamin D the metabolites and the route of administration. These 
challenges were evident in our meta-analysis of vitamin D supplementation and 
muscle strength and mobility (Paper I) as was indicated by the high degree of 
heterogeneity between studies. Changes in health outcomes such as muscle strength, 
mobility and BMD usually do not occur quickly, but develop slowly over time. This 
means that the habitual diet and lifestyle have a greater effect on these outcomes than 
supplementation administered for a short period of time (240). However, 
supplementation use should not be ruled out, but may have a place in addition to the 
habitual diet. However, supplementation should be evaluated according to the 
participants’ deficiency/sufficiency status, the age, the total energy intake and the 
dietary quality. As an illustration, vitamin D and calcium supplementation is 
recommended to prevent low BMD to those with low vitamin D and calcium intake 
(241). Another issue for comparison of food and supplementation is the case of fish 
and n3 PUFAs. Opposed to the many intervention studies on health effects of          
n3 PUFAs, there are only limited number of intervention studies on fish with clinical 
outcomes. As an illustration, to the best of our knowledge, we did not find an 
intervention with fish for the prevention of sarcopenia. However, RCTs using          
n3 PUFAs have been conducted in primary prevention of sarcopenia and have 
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reported positive results (242-244). Even further, n3 PUFA supplementation also had 
positive effects on muscle mass in sarcopenic older persons (245). Thus, it has to be 
shown whether an intervention with fish would have similar results.  
 
6.2.2 Predictors for preserving muscle and bone mass with aging 
Both loss of muscle mass (sarcopenia) and loss of bone mass (osteoporosis) are 
conditions that are part of the aging process. Although the reasons for the reduction 
of muscle and bone mass are multifactorial, they have several factors in common, 
including reduced physical activity, reduction of sex hormones, and catabolic stimuli 
due to chronic inflammation (246). The loss of muscle mass has implications for 
muscle strength and mobility, often indicated by an increased risk of falls (247, 248). 
The loss of bone mass leads to an elevated risk of low-energy fractures. Older 
persons suffering from both sarcopenia and osteoporosis are at an increased risk of a 
fall and fracture (249), and the term osteosarcopenia recently has been introduced 
(250) for these particularly frail individuals. Not surprisingly, the prevalence of 
sarcopenia is high in hip fracture patients, ranging from 17- 58% using the EWGSOP 
definition on sarcopenia (251-253).  
Among the many risk factors of osteoporosis and sarcopenia, some are 
unmodifiable. Low BMD is associated with female gender (30), ethnicity (254, 255), 
familial history of osteoporosis (256, 257) and genetic factors, which account for 
about 70 % of BMD variability (33, 258). In muscle mass, the genetic implications 
and sex differences are also evident, and, similarly as in BMD, a high proportion of 
the variability in lean mass is thought to be explained by genetic factors (33). In both 
low BMD and muscle mass, the modifiable risk factors, accounting for only some 20-
40% of the variability. These include smoking (27, 259), little physical activity (26, 
260), and the diet (33, 49). Thus, diet plays a limited, but important, role in the 
prevention of low BMD and muscle mass. Since a low BMD is one of the strongest 
risk factors for hip fractures (48), the above-mentioned factors are relevant for hip 
fracture prevention as well. In both preserving muscle and bone mass, a combination 
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of nutritional factors and physical activity seems to be the key modifiable factors (33, 
261). Physical activity is an important measure owing to its stimulation of protein 
synthesis in muscles (24) and mechanical loading that promotes bone strength     
(260, 262). Physical activity also increases the energy requirement and appetite (263), 
and is therefore associated with higher dietary intake, which is positive in this regard.  
Bearing in mind that adequate energy intake and quality of the diet make an 
important contribution to healthy aging, it is astonishing that dietary 
recommendations so far have not been focused particularly on very old persons   
(older than 80 years). Owing to the age-dependent muscle loss and the reduced 
physical activity, the energy requirements in healthy older persons are decreased 
compared to younger adults. Owing to anabolic resistance, the utilization of dietary 
protein in protein synthesis and the counteractive effect on muscle degradation is 
reduced (24), which indicates higher protein requirements (264). The European 
Society for Clinical Nutrition and Metabolism (120) has already suggested higher 
protein recommendations for older persons but this has not been considered in 
national recommendations. In the NNR5 (91), the lower limit of protein 
recommendation is higher for older than for younger persons, but at the same time, it 
is expressed that there is huge uncertainty on the protein requirements in older 
persons.  
In contrast to energy requirements, those for vitamins and minerals, however, 
remain the same or increase. This is due to a number of physiological changes, such 
as the reduced absorption in the gastrointestinal tract, reduced number of parietal 
cells in the stomach, and less effective skin synthesis of vitamin D (75). In the case of 
vitamin D, there are already recommendations for older persons (Table 4), which 
refer to both changed physiology and increased risk of fractures.  
At present, there is huge uncertainty about the nutritional needs for very old 
persons. Their requirements are further affected by the high burden of chronic 
diseases and medication use. This is a field of research with extensive knowledge-
gap. There is a need for more research in the health effects of diet in older persons.  
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7. Conclusion 
Community-dwelling older persons did not benefit from vitamin D supplementation 
in terms of muscle strength and mobility. In older women, high fish intake seems to 
have beneficial effects on BMD that, however did not translate into reduced risk of 
hip fractures. One possible explanation could be that other factors are more important 
than fish intake in this cohort of well-nourished, community-dwelling old women. 
Although we observed a small risk increase of hip fractures in old men who were in 
the lowest quartile of fish consumption, these results should be interpreted with 
caution, as we did not see any effect on BMD in men and no association of fish intake 
with hip fracture risk in women. Thus, a chance finding cannot be excluded.  
The most important conclusions from the clinical study are first, that older 
persons admitted to the hospital are difficult to motivate to participate in a clinical 
study. This is shown by the relative low number of patients and the high attrition rate. 
Secondly, hip fracture patients are a high-risk group of developing undernutrition. 
About ¾ of the included patients lost weight during the first three months post 
fracture, which was negatively associated with mobility at this time point.  
Overall, there is a need for more high quality studies of the association of 
health outcomes and diet in community-dwelling older persons. This requires joint 
efforts from health professionals including clinical dietitians, physiotherapists, 





8. Further perspective 
Loss of muscle mass is one of the characteristics of aging. Low physical activity, low 
dietary quality, smoking and polypharmacy are among the factors that accelerate this 
process and thereby the risk of developing sarcopenia. Acute and chronic diseases 
that are common in an aging population also contribute to this development. Thus, 
future studies should include patients with chronic diseases such as cardiovascular 
disease, cancer, chronic obstructive pulmonary disease, and osteoporosis and 
investigate the prevalence of sarcopenia. Furthermore, determinants of loss of muscle 
mass and treatment options to maintain muscle mass in older persons should be 
investigated. Promising prevention and treatment interventions involve dietary 
(adequate energy and protein intake), lifestyle (physical activity and smoking 
cessation) and pharmaceutical (prevention of polypharmacy) measures.  
As argued in the present thesis, there is uncertainty concerning the dietary 
recommendations for older persons. There is an extensive knowledge-gap for the 
dietary needs of this population group. To fill this gap, it requires joint efforts form 
the scientific community in collaboration with those working in primary and 
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Abstract
Background: It has been suggested that vitamin D status or supplementa-
tion is important for maintaining or improving muscle strength and mobil-
ity in older adults. The study results, however, do not provide consistent
results. We therefore aimed to summarise the available evidence systemati-
cally, including only studies conducted in community-dwelling older per-
sons.
Methods: A systematic search of the literature was performed in April of
2016. The systematic review includes studies that used vitamin D with or
without calcium supplementation as the exposure variable and various mea-
surements of muscle strength and mobility. The meta-analysis was limited
to studies using hand grip strength (HGS) and timed-up-and-go test as the
outcome variables.
Results: A total of 15 studies out of 2408 articles from the literature search
were included in the systematic review, providing 2866 participants above
the age of 65 years. In the majority of studies, no improvement in muscle
strength and mobility was observed after administration of vitamin D with
or without calcium supplements. In the meta-analysis, we observed a non-
significant change in HGS [+0.2 kg (95% confidence interval = 0.25 to
0.7 kg; seven studies)] and a small, significant increase in the timed-up-
and-go test [0.3 s (95% confidence interval = 0.1 to 0.5 s; five studies)]
after vitamin D supplementation. The meta-analyses showed a high degree
of heterogeneity between the studies.
Conclusions: In conclusion, we observed no improvement in muscle
strength after the administration of vitamin D with or without calcium sup-
plements. We did find a small but significant deterioration of mobility.
However, this is based on a limited number of studies and participants.
Introduction
Among other changes in body composition and functions,
ageing involves a decrease in skeletal muscle mass and
strength, and consequently also in mobility (1). This loss
of muscle mass and strength is called sarcopenia and is
associated with falls, fractures, immobilisation and
mortality. Sarcopenia has an estimated prevalence of
5–13% in 60–70 year olds and 11–50% in persons older
than 80 years (2). These numbers demonstrate that declin-
ing muscle mass and strength are significant and
age-dependent problems in older persons. Early and con-
tinuous interventions may be key to limiting this decline
and preserving both muscle mass and strength. A number
1ª 2016 The Authors Journal of Human Nutrition and Dietetics published by John Wiley & Sons Ltd on behalf of British Dietetic Association
Journal of Human Nutrition and Dietetics
of dietary measures (supplementation with protein,
energy, or n-3 polyunsaturated fatty acids, micronutrient
supplementations) (3–8) and exercise interventions (9,10) or
their combinations have been tested (11–14). Among these
interventions, supplementation with vitamin D has been
promoted as having positive effects in older persons with
respect to the risk of falls and fractures (15,16). Usually,
meta-analyses investigating the effect of vitamin D on the
risk of falling include studies using vitamin D either with
or without calcium supplements. Therefore, it is impossi-
ble to conclude whether vitamin D supplementation
would be effective on its own or not. This can be
regarded as a serious limitation of previous randomised
controlled trials (RCTs) and meta-analyses and can also
lead to inconsistent conclusions (17). In a newer meta-
analysis investigating primarily the effect of vitamin D on
hip fractures in older adults (18), however, it was con-
cluded that vitamin D with calcium was effective in pre-
venting fractures, although the effect of vitamin D
without calcium was not significant. An increased risk of
falls can be seen as a consequence of low muscle strength
and mass (19). It has been estimated that the risk of falls
increases with age and the presence of frailty and falls are
a common cause of fractures in old adults (20). The inci-
dence of falls is difficult to measure, and falls may also
have many other causes. Direct measurements of muscle
strength and mobility are therefore required to study the
effect of vitamin D.
Vitamin D deficiency is widespread in adult and older
populations (21), even in populations without other overt
nutrient deficiencies (22). Vitamin D supplementation is
usually combined with calcium supplementation, aiming
to ensure sufficient calcium from the diet during vitamin
D supplementation (23,24). Vitamin D may exert its influ-
ence on skeletal muscle cells by the presence of the vita-
min D receptor, and may also be needed for optimal
muscle function (21) and adequate protein synthesis. In
observational studies, an adequate 25(OH)D concentra-
tion was associated with better musculoskeletal function
and muscle strength (25,26). However, the optimal level of
25(OH)D in older persons is still unknown, although it is
suggested to be ≥65 nmol L1 (27).
Older people represent a very heterogeneous group. In
general, community-dwelling older persons are younger
and in better health and a better functional state com-
pared to institutionalised individuals, although a high
prevalence of comorbidities of chronic diseases may be
present. In particular, institutionalised older persons show
higher degrees of frailty, are more dependent in activities
of daily living, and have a higher prevalence of cognitive
decline. It is therefore justified to distinguish between
these two groups when analysing dietary measures aimed
at reducing the decline in muscle strength and mobility,
although a number of studies did not make this distinc-
tion (28–33). However, vitamin D supplementation for the
prevention of loss of muscle strength and mobility has
not been established in either group. In addition, studies
vary in their design, the type and length of the interven-
tion, and the outcomes because different measurements
of muscle strength and mobility have been used, and
there is no common protocol for these assessments.
The objective of this systematic review and meta-analy-
sis was to investigate the effects of vitamin D supplemen-
tation (with or without calcium) in community-dwelling
older subjects on muscle strength and mobility, based on
the results from RCTs.
Materials and methods
Data sources and search strategy
Relevant studies were identified by a systematic search of
current literature using PubMed, Embase, Medline, Web
of Science and the Cochrane Library, followed by a man-
ual search of the extracted articles and existing reviews.
The clinical trial registry ‘ClinicalTrials.gov’ was searched
for unpublished trials. The search covered the period up
to 13 April 2016. The search terms are presented in the
Supporting information (Appendix S1).
The inclusion criteria are stated in Table 1. Differences
in dosage, frequency, mode of delivery or the form of the
vitamin D supplementation were not a cause for exclusion.
It became apparent that only the outcomes comprising
hand grip strength (HGS) and timed-up-and-go (TUG)
were investigated in a sufficient number of studies to per-
form a quantitative meta-analysis, whereas other outcomes
of muscle strength and mobility were only included in the
systematic review. Two of the authors (HRR, JD) screened
the article titles and abstracts to identify studies that were
suitable for inclusion. Ninety-four articles were read as full
Table 1 Overview of the inclusion criteria for the present systematic
review and meta-analysis
Design Randomised controlled trials
Participants Older persons >65 years of age
Humans
Community-dwelling
Intervention Vitamin D supplementation – all forms and
all doses, with or without calcium
supplements or dietary advice
Comparator Low dose of vitamin D or vitamin D
metabolites or placebo, with or without
calcium supplement
Outcome measures
Systematic review Measures of muscle strength and mobility
Meta-analysis Hand grip strength (HGS)
Timed-up-and-go test (TUG)
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papers, and 15 studies were selected for systematic review
(Fig. 1). These 15 studies also included one identified by
searching clincialtrials.gov (34). The 15 articles were evalu-
ated by all authors. Three other studies identified from
clinicaltrials.gov were either still ongoing or a study proto-
col, and were therefore not included.
The various outcomes used in these studies are
described in the Supporting information (Appendix S2).
The overall quality of the full articles was assessed using
the CONSORT statement checklist for assessing quality of
randomised clinical trials (35). The CONSORT statements
are summarised in the Supporting information
(Appendix S3).
Data collection
All relevant information was extracted from eligible stud-
ies and is available in Table 2. Any other information
necessary for the review, such as potential covariates to
the RCT (e.g. the season in which the RCT took place
and any ultraviolet-B exposure), the dropout rate and
compliance, was also noted when reported.
MEDLINE, PubMed, Embase, 
Web of Science and Cochrane 
Library were searched 
electronically.
2408 potential articles were 




10 not a study
94 articles extracted for full 
assessment and abstracts 
assessed for possible 
inclusion
15 studies included for 
systematic review
79 studies excluded because they 
did not correspond to the inclusion 
criteria:
2 nursing home residents
5 exercise as a co-intervention
1 hormone therapy as co-
intervention
1 protein supplement as an 
intervention
5 severely/chronically ill patients
7 outcome not muscle strength or 
mobility
3 irrelevant content
5 studies on adults




10 studies included for 
the meta-analysis
7 for outcome hand grip 
strength (HGS) 
5 for outcome timed-up-and 
-go (TUG)
5 studies were excluded 
for meta-analysis 
because of other 
physical performance
outcomes
Figure 1 Flow chart of the selection of studies on
the effect of vitamin D supplementation with or
without calcium supplements on muscle strength and
mobility in the present systematic review and meta-
analysis. RCT, randomised controlled trial.
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Statistical analysis
Other outcomes than TUG and HGS were reviewed narra-
tively as a result of the low number of studies evaluating
these outcomes. Only for TUG and HGS did we find more
than three studies for a quantitative meta-analysis. We
used RevMan, version 5.3 (Cochrane collaboration) (36) for
the analysis, with the outcome being represented by Forrest
plots (Figs 2 and 3). Weighted mean differences for vita-
min D versus placebo/control were calculated by subtract-
ing the mean of the outcome of interest at the end of the
study from the mean at baseline. Standard deviations
(SDs) of the differences were calculated using a formula
given in the Cochrane Handbook (37), applying correlation
coefficients of 1.0 for the HGS and 0.8 for the TUG-test.
Because significant heterogeneity was observed between
studies with a fixed effect model, we finally applied a ran-
dom effects model. Studies that included more than one
intervention group (38) were treated by dividing the num-
ber of subjects in the control group by the number of com-
parisons at the same time as retaining the mean (SD) of
the change according to the Cochrane Handbook (37).
Subgroup analysis was conducted with predefined study
characteristics: baseline vitamin D status, oral administra-
tion of the supplement, daily dose of vitamin D, placebo
group, supplementation with vitamin D2 or D3, and
advice on calcium supplementation to explore possible
reasons for the observed heterogeneity (39,40).
Results
Search results
As per the Quality of Reporting of Meta-analyses
(QUOROM) (41) flow diagram (Fig. 1), 15 out of 2408
studies were included in the systematic review and 10 of
the 15 were eligible for the meta-analysis.
Narrative review
Study characteristics
We included a total of 15 studies, with a total of 2866
participants aged 65 years and older. Two studies were
included with an average age of the participants of
63.8 years (range 60–70 years) (38) and 61.5 years (range
50–70 years) (42), whereas the average age in the other
studies included was between 70 and 80 years. The ratio
of men to women was approximately 1 : 9 (229/2044),
not including one study that did not specify the partici-
pants’ sex (n = 593) (43). The studies were conducted in
Figure 2 Results of the meta-analysis of the effect of vitamin D supplementation with or without calcium on hand grip strength (kg) (n = 7
studies). The results were obtained using a random effects model. One study reported results for men and women separately (Lagari a – men
and Lagari b – women). For one study, we have divided the comparator group in two (Wood-a and Wood-b). CI, confidence interval.
Figure 3 Results of the meta-analysis of the effect of vitamin D supplementation with or without calcium on timed-up-and-go (TUG) (n = 5
studies). The results were obtained using a random effects model. CI, confidence interval.
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Australia, China, Thailand, USA, Canada and Europe
(Germany, Austria, Netherlands, Switzerland, Scotland
and the UK). One study was a multicentre study, with
centres in North America, Mexico and Europe (43). The
participants were all community-dwelling older persons,
who were generally in age-related good health, and a his-
tory of chronic conditions such as cardiovascular disease
was usually not treated as an exclusion criterion. All stud-
ies excluded patients with acute diseases. In general,
underlying diseases serving as exclusion criteria were not
sufficiently described.
The vitamin D status was measured as the 25(OH)D
concentration in 13 of the 15 studies, with chromato-
graphic methods being used in four of them (38,42–44).
Other studies used radioimmunoassay (DiaSorin Inc.,
Stillwater, MN, USA) (34,45–47), IDS Gamma-B 25-OH
immunoassay (IDS, Tyne & Wear, UK) (48), Liaison
method (DiaSorin Inc.) (49,50) microassay as described per
Reinhardt et al., 1984 (51), competitive protein binding
(Endocrine Science Inc., Calabasa Hills, CA, USA) (52).
One study did not report what method had been used
(53).The mean baseline serum 25(OH)D concentration
ranged between 25 and 82 nmol L1 (54). The average
concentration exceeded the cut-off level of 50 nmol L1
for defining a sufficient status, in six of the 15 studies (44–
46,49,51,52) and, on average, was below that value in eight
of them (34,38,42,43,47,48,50,53) and was not reported in one
study (55).
All of the studies selected declared that they had a ran-
domised parallel design. Three did not have a placebo
group but used a low dose of vitamin D3 (400 IU day
1)
as a control (44,55) or the recommended dose for elderly
(800 IU day1) (42). One study did not state whether it
had been blinded or not (45). One was a randomised,
multicentre, open-label, placebo-controlled study (55). The
randomisation process was usually not sufficiently well
described.
Seven of the 15 studies included calcium with vitamin
D supplement or placebo (43,45–47,52,53,55). Three studies
assessed the intake of supplements or dietary calcium
intake (34,44,51). One study specified calcium supplementa-
tion or dietary intake of calcium of 1300 mg (47). Two
studies assessed the overall nutrient intake (38,50). One
study excluded participants using high-dose (>600 mg)
calcium supplements (42). One study did not consider cal-
cium intake at all (48).
Both season and latitude can be important covariates
as a result of internal vitamin D production by ultravio-
let-B radiation (21). The season of blood withdrawal was
not stated in six of the 15 studies (34,42,50,53,55) and the
geographic latitude was stated in three (38,45,47). Other
covariates of vitamin D status (body mass index, ethnic-
ity, smoking) were usually not considered specifically.
The exception was one study that specifically investigated
the effect modification of different body mass index
groups (normal, overweight and obese) in participants
with Caucasian ethnicity (38).
The dropout rate was given in 13 of the studies, and
ranged from 0% to 22%. In one of these studies, the
dropout rate was given in another publication (56). In one
study, the authors noted that the dropout rate was low,
without further details (34); in one study, the dropout rate
was not reported at all (44).
Compliance was not mentioned in four of the 15 stud-
ies (43,46,52,55). In eight of the studies, the compliance was
reported to be better than 80% (38,42,44,47,49–51,53). One
study used bolus injections, so that 100% compliance
may safely be assumed (48). In one study, the compliance
rate was 100% for the participants completing the study
(49). In one study, the authors stated that a daily compli-
ance calendar had been kept but did not report on com-
pliance (34).





(51,55), alfacalcidiol (46) or 25(OH)
D3
(42) with various doses, administration routes and
treatment periods, ranging from bolus injection of
600 000 IU of vitamin D2
(48); 1000 IU daily oral dose of
vitamin D2
(47); oral vitamin D3 in doses of 150 000 IU
every 3 months (49); weekly oral dose of 8400 IU vitamin
D3
(43); and daily oral supplement in doses ranging from
400 to 4000 IU vitamin D3
(34,38,44,45,50,52,53). The studies
that used 1,25-dihydroxyvitamin D used a daily oral dose
of 1,25-dihydroxyvitamin D (0.5 lg) compared to pla-
cebo (51) or 125 IU (vitamin D3) compared to 0.25 lg
calcitriol 125 IU1 (55). One study included four groups
comparing different doses of vitamin D3 (800 IU day1
and 5600 IU week1) with 25(OH)D3 (20 lg day
1 and
140 lg week1) (42).
An overview of the methodological quality of the stud-
ies is presented in the Supporting information
(Appendix S3).
Study outcomes
Measurements of physical performance outcomes are not
standardised, and various methods had been used in the
clinical studies (see the Supporting information,
Appendix S2). Four studies used complex outcome mea-
surements such as the Short Physical Performance Battery
(including TUG) (34,43,52) and the aggregate functional
performance time (48).
Studies that used single outcome measurements
included the knee extension test (34,42,50,53). Three studies
used quadriceps strength (using various protocols
thus precluding a formal meta-analysis) (45,46,48),
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HGS (38,44,49,51–53,55) and the 3-m TUG (42,45,47,49,50,52).
Other available physical outcome measures were the 4-m
TUG, leg muscle strength, leg extension strength, gait
speed, Five-Times-Sit-to-Stand-Test, leg extension power,
modified Cooper test, stair climbing power, the four
square step test, repeated sit-to-stand, knee flexion
strength and lower limb muscle strength.
The authors of nine studies concluded that supplemen-
tation with vitamin D and/or calcium did not have
any beneficial effect on mobility and/or muscle
strength (34,38,43,44,48,49,51–53). In six studies, they found
an improvement in mobility and/or muscle strength
(42,45–47,50,55). One of the four studies that used a complex
outcome measurement reported a beneficial effect for the
mobility outcome (48). Three of the studies reporting an
improvement in either measure only observed this in the
subjects who had been weakest and slowest at baseline
(47) or in those with pre-existing low levels of 25(OH)D3
(42,46). In the case of one study (47), no subgroup analysis
had been prespecified in the record of the trial registry
(clinicaltrials.gov).
The meta-analysis
We performed meta-analyses for the outcomes HGS (kg)
and TUG (s).
Hand grip strength
The meta-analysis included seven studies (38,44,49,51–53,55),
with 767 participants treated with vitamin D and 639
participants treated with control (low-dose vitamin D or
placebo). HGS was measured using various devices and
protocols, giving an average HGS at baseline of between 3
and 23 kg. Applying a random effects model, we observed
a nonsignificant improvement in HGS after vitamin D
supplementation, amounting to 0.2 kg [95% confidence
interval (CI) 0.3 to 0.7 kg]. The meta-analysis revealed
significant heterogeneity between the studies (I2 = 97%),
which was completely eliminated by omitting the three
studies that included subjects with vitamin D deficiency
(38,53,55). After exclusion of these three studies, the effect
on the HGS became significant (0.40, 95% CI = 0.37 to
0.43kg). Other sensitivity analyses (Table 1; see also Sup-
porting information, Appendix S4: exclusion of studies
using vitamin D2, using bolus doses of vitamin D or
inclusion of calcium supplements) did not diminish the
heterogeneity between the studies and did not change the
overall result of a marginal effect of vitamin D supple-
mentation on HGS (Fig. 2).
Timed-up-and-go
The meta-analysis included five studies (45,47,49,50,52) with
638 participants treated with vitamin D and 622
participants treated with a control or placebo. The studies
reported average TUG results ranging from 5 to 11 s.
Applying a random effects model, we observed a signifi-
cant mean increase of 0.3 s in the TUG (95% CI = 0.1 to
0.5 s) after vitamin D supplementation. Thus, the
increase would mean a deterioration of the TUG result
after vitamin D supplementation. The meta-analysis
revealed significant heterogeneity between the studies
(I2 = 95%) (Fig. 3). A sensitivity analysis excluding Zhu
et al. (47) (who used vitamin D2 as a supplement and
included participants with an average 25(OH)D concen-
tration lower than 50 nmol L1) lead to an insignificant
overall estimate of 0.2 s (95% Cl = 0.03 to 0.4s) but
did not affect the heterogeneity (sensitivity analysis pre-
sented in Table 2; see also Supporting information,
Appendix S4).
Discussion
The objective of this systematic review and meta-analysis
was to investigate whether vitamin D supplementation
(with or without calcium) in community-dwelling older
persons can improve muscle strength and mobility. For
the present review, 15 RCTs were included for revision,
whereas 10 were suitable for the meta-analysis. Based on
findings in nine of the studies, it was concluded that sup-
plementation with vitamin D and/or calcium did not
have any beneficial effect on mobility or muscle strength,
or on both (34,38,43,44,48,49,51–53). The main findings of the
quantitative meta-analysis indicated that supplementation
with vitamin D did not improve the HGS (based on
seven studies) to any significant extent and even had a
worsening effect on the TUG-test results (based on five
studies). Therefore, vitamin D supplementation appears
to be of limited value for the preservation of muscle
strength and mobility in an older population.
Study population
The older population is heterogeneous in age and the
related frailty, as well as with respect to the prevalence of
chronic diseases and their treatment, and dependence in
the activities of daily life. It can therefore be expected that
studies in older persons in general will yield mixed results
unless the population is defined more accurately accord-
ing to the factors mentioned. We therefore limited the
present meta-analysis to community-dwelling older per-
sons in apparently age-related good health, although, in
many cases, the health status had not been sufficiently
well described.
Community-dwelling older persons are usually in much
better health than those hospitalised or living in nursing
homes. Targeting these subjects with an intervention
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aimed at preserving muscle strength and mobility thus
appears sensible. However, in concordance with our find-
ings, studies on vitamin D supplementation in hospi-
talised older subjects (57,58) or residents in nursing homes
(3,7) showed mixed results for the effects of vitamin D
supplementation on muscle strength and mobility. Thus,
convincing evidence that vitamin D supplementation may
be a useful measure is lacking (14,28,59).
Most studies recruited only or predominantly women.
Although, at present, there is little evidence that the diet-
ary requirements for vitamin D are different in older men
and older women (60), or that the effects of vitamin D on
muscle strength are different in older men and women,
there is clearly a lack of data on the effect of vitamin D
supplementation in men.
Intervention
Vitamin D exists in two different forms (D3 and D2). In
addition, the inactive form [25(OH)D] and the active
form of the hormone [1,25(OH)2D], different routes of
administration (oral or intravenous, daily/weekly or bolus
supplementation), as well as various doses and various
durations of supplementation, can be used. These aspects
further complicate comparison of the studies and can
introduce heterogeneity between the studies. High-dose
bolus supplementation (either oral or intravenous) has
the advantage of high compliance, especially in older sub-
jects who already take a number of medicines on a daily
basis. Doses of 300 000 IU are an established treatment
for vitamin D deficiency and are regarded as safe. How-
ever, doses over 500 000 IU should be avoided because
adverse effects of such high doses such as increased falls
and fracture risk have been reported (61,62).
The studies using a low dose were included in the
meta-analysis as a result of studies by Lagari et al. (63)
and Chao et al. (64) stating that 400 IU was inadequate to
increase the 25(OH)D concentrations to an acceptable
level regardless of baseline 25(OH)D levels in older per-
sons. Because of the high dose of vitamin D3 used as a
control group in the study by Bischoff-Ferrari et al. (42),
we choose not include the study in our meta-analysis.
Outcomes
The functional improvement in the older persons has
been measured using a range of measurements employing
different protocols. Among these, the HGS has been
shown to be a reliable parameter (65,66) for long-term
health outcomes. There is, however, less evidence for the
TUG test for long-term health outcomes.
We included only quantifiable outcomes in the present
study but not falls or fractures that have been used as
measure of reduced muscle strength and as clinical out-
comes in other studies (15,67). However, determining falls
may be difficult in community-dwelling older persons
because it relies heavily on the subjects’ recall and may
thus reduce the reliability of this outcome.
We observed a small and nonsignificant improvement
in HGS as a result of vitamin D supplementation in the
meta-analysis, which was also characterised by a high
degree of heterogeneity between studies. However, the
magnitude of the effect may also indicate that other
health measures, such as exercise and potentially supple-
mentation with other nutrients, should be prioritised. In
addition, the huge variation in baseline HGS measure-
ments between studies further complicates the interpreta-
tion of the effects of high/increased vitamin D intake.
The nonsignificant result may be regarded as contradict-
ing observational studies in community-dwelling older
persons because other studies have reported that a dou-
bling of the 25(OH)D concentration from 50 to
100 nmol L1 was associated with a higher HGS in men
and in women, with increases of approximately 4.4 and
0.8 kg, respectively (68). We observed a significant and
stronger improvement of HGS and diminished hetero-
geneity after the exclusion of three studies with low 25
(OH)D concentrations at baseline (38,53,55). Low vitamin
D status may reflect a higher degree of frailty (69), and
supplementation may therefore be too late to improve
muscle strength in those with very low 25(OH)D levels,
despite the correction of vitamin D deficiency as indi-
cated by the serum levels.
Although the effect of vitamin D supplementation on
the TUG test suggests a negative direction by increasing
the time used for the test, this result should be taken with
caution because the meta-analysis showed a high degree
of heterogeneity that was not removed by excluding single
studies (Table 2; see also Supporting information,
Appendix S4). In addition, the overall magnitude of the
effect was very small, suggesting that this change is clini-
cally less meaningful. Overall, the small number of studies
and the high degree of heterogeneity precludes any firm
conclusions, although further investigations are certainly
warranted. It would be interesting to determine whether
interventions combined with exercise and/or other nutri-
ents would improve the test outcome. This has already
been shown by Bunout et al. (12), who used exercise and
vitamin D supplements as interventions in vitamin D-
deficient community-dwelling older persons and observed
a positive effect on TUG.
The importance of calcium supplements should also be
considered. Because of the concurrent administration of
calcium in most and especially in the larger studies (43,45–
47,49,52,53,55), it is impossible to determine any indepen-
dent effect of either vitamin D or calcium. The use of
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calcium supplements for purposes other than improve-
ment of bone health has been strongly debated. It is also
plausible to combine vitamin D supplements with cal-
cium because vitamin D increases calcium absorption
from the gut but, in the case of insufficient dietary cal-
cium intake, this can also affect bone remodelling (70).
Comparison with previous systematic reviews and meta-
analyses
The effect of vitamin D on physical performance has been
summarised in systematic reviews (28,30,33) and in three
meta-analyses (29,31,32). These investigations are charac-
terised by either including all age groups (30–32), by
including older adults from different settings (commu-
nity-dwelling and institutionalised, (14,28,29), different
study designs (33) and investigating composite outcomes
(32), thus making comparisons with our findings difficult.
Stockton et al. (31) also reported a meta-analysis for HGS
and, in line with our findings, reported no significant
effect on HGS. The only other meta-analysis that reported
TUG as an outcome reported a small, significant
improvement of this test, based on three studies (29).
Thus, the overall results are difficult to compare,
although they demonstrate the large number of tests used
for the assessment of muscle strength, physical perfor-
mance and mobility. A common test battery would make
comparisons between studies much easier.
Strengths and limitations
The strengths of this review include the use of data from
15 RCTs, with approximately 2800 participants treated
with vitamin D or a control, and the analysis of quantita-
tive outcomes such as HGS and TUG, which have been
shown to be related to other clinical outcomes in the
older persons (71).
The main limitation of this review is the small num-
ber of studies available for the meta-analysis, mainly as
a result of heterogeneity of the measurements used.
Another limitation is the variation in study populations,
with a wide range of comorbidities. More exact descrip-
tions of the population under study are urgently needed
to improve comparability of studies and to increase
external validity. We also observed heterogeneity
between studies that could not be resolved by subgroup
analyses.
In conclusion, we observed no improvement in muscle
strength after administration of vitamin D with or with-
out calcium supplements. We did find a small but signifi-
cant deterioration of mobility. This is, however, based on
a limited number of studies and participants.
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Abstract: Hip fractures have a high prevalence worldwide. Few studies have investigated whether
fish consumption is associated with risk of hip fractures. The objective of the present study was
to investigate the effect of fish intake on the subsequent risk of a hip fracture because of the low
number of studies on this topic. A community-based prospective cohort study of 2865 men and
women from Hordaland county in Norway, born between 1925–1927 and enrolled in the study in
1997–1999. Information on hip fracture cases was extracted from hospital records until 31 December
2009. Baseline information on the intake of fish was obtained from a semi-quantitative food frequency
questionnaire. Cox proportional hazard regression models with death as a competing risk were used
to evaluate the association of fish intake with risk of hip fracture. During a mean (SD) follow-up time
of 9.6 (2.7) years, 226 hip fractures (72 in men, 154 in women) were observed. The mean (SD) fish
intake was 48 (25) g/1000 kcal. The association between fish intake and risk of hip fracture was not
linear and displayed a threshold, with low intake of fish being associated with an increased risk of hip
fracture in men (HR (Hazard Ratio) = 1.84, 95% CI 1.10, 3.08). In this community-based prospective
study of men and women, a low intake of fish was associated with the risk of a hip fracture in men.
Keywords: diet; food frequency questionnaire; fish intake; hip fractures
1. Introduction
Hip fracture is a major public health challenge in aging populations worldwide with especially
high prevalence in Caucasian populations [1]. Hip fractures substantially increase the risk of morbidity
and death in older persons [2,3]. The one-year mortality is about 10–30 percent depending on sex,
mental health, and comorbidity burden before the fracture [4–7]. Low bone mineral density (BMD)
is the strongest single risk factor for hip fracture and it has been estimated that the risk ratio for
hip fracture in men and women increases threefold for each standard deviation (SD) reduction in
BMD [8,9]. However, as there are no good biomarkers or clinical signs of changes in BMD, a hip
Nutrients 2018, 10, 873; doi:10.3390/nu10070873 www.mdpi.com/journal/nutrients
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fracture is often the first sign of low BMD [9]. Postmenopausal women have a more drastic decrease in
BMD than men of the same age do. Because women also have a longer life expectancy than men, the
majority of low-energy hip fractures occur in women [9].
In addition to low BMD and sex, additional modifiable risk factors such as smoking [10], high
alcohol consumption [11], low body weight [12,13], and low physical activity [14] are associated with an
increased risk of hip fracture. Diet is discussed as another modifiable risk factor. Much focus in the past
has been on single nutrients such as protein [15,16], calcium [17], vitamin D [18], vitamin K [19], and
omega-3 polyunsaturated fatty acids (n-3 PUFAs) [20]. There is also some evidence that dairy products,
as good sources of calcium [21], and a high intake of fruit and vegetables are associated with a lower
risk of hip fracture [22,23]. Other food groups, including fish, have been investigated to a lesser degree.
Because fish contains several potentially beneficial nutrients, including high quality protein, vitamin
D, selenium, iodine, and n-3 PUFAs, it is an interesting food group with respect to prevention of hip
fractures. Published articles provide mixed results on the association between fish intake and risk of hip
fracture; two prospective studies reported a non-significant association [24,25], whereas a case-control
study reported a protective effect of high fish intake [26]. In addition, studies have investigated fish as
a part of a dietary pattern and reported beneficial but non-significant associations [22] or a beneficial
significant effect [27,28]. Thus, the role on fish intake on hip fracture risk is uncertain.
Fish intake shows a high variation among populations, with Spain, Iceland, and Norway on top
in the Western world. Total fish intake in these countries is about 50–70 g per day on average and is
thus about 3–4 times that of central European countries [29] and the US [24,25].
Studying a Norwegian population of old men and women with among the highest hip fracture
prevalence in the world, and with habitually high fish consumption, gives the unique opportunity to
investigate total fish intake as well as sub-groups of fish. Thus, the main objective of this study was to
investigate the relationship between total, lean, and fatty fish intake and the risk of hip fracture in the
Hordaland Health Study (HUSK).
2. Materials and Methods
2.1. Subjects
We used data from the large community-based Hordaland Health Study (HUSK), Western
Norway [30]. Participants were born between 1925–1927 and the baseline examinations were conducted
during 1997–1999 [31]. Information on hip fractures was collected from the hospitals located in
Hordaland County.
2.2. Dietary Assessment
The dietary assessment, questions related to dietary intake of fish and categorization of alcohol
consumption, has previously been described in detail [32,33]. Briefly, habitual dietary intake was
assessed using a 169-item food frequency questionnaire (FFQ) developed at the Department of
Nutrition, Institute of Basic Medical Sciences, University of Oslo. The FFQ has been validated
against weighted dietary records and against fatty acid composition in serum phospholipids [34–36].
Participants with an energy intake lower than 700 kcal or 800 kcal and higher than 3600 kcal or 4200 kcal
for women and men, respectively, were removed from the analyses, leaving 2865 participants.
In addition to total fish intake (lean, fatty, and processed fish), fish intake was divided into
fatty fish (herring, mackerel, salmon, trout, and fish used as spread) and lean fish (cod, pollock, and
haddock). The multivariate nutrient density method was used for energy adjustments [37] of all dietary
variables and presented as g/1000 kcal (foods and micronutrients) or energy percent (macronutrients).
Total marine n-3 PUFA intake was calculated by adding eicosapentaenoic acid (EPA), docosapentaenoic
acid (DPA), and docosahexaenoic acid (DHA).
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One alcohol unit was defined in accordance with the Nordic Nutrition Recommendations 2012 [38].
Sex specific categories of alcohol intake was defined as: 0 = 0 g/day; 1 = women: >0–10 g/day; men:
>0–20 g/day; 2 = women: >10–20 g/day; men: >20–30 g/day; 3 = women: >20 g/day; men: >30 g/day.
2.3. Hip Fractures
Collection of information on hip fractures and death has been previously described [39,40], along
with a validation of the collection method [41]. Briefly, information on hip fractures was obtained
from computerized records containing discharge diagnoses for hip fractures from all hospitalizations
between the baseline examinations in HUSK through until 31 December 2009 at the six hospitals in
Hordaland County, Norway. Participants were followed until they experienced their first hip fracture
or died. A hip fracture was defined as the first fracture of the proximal femur during the observation
period. Information on time of death was obtained from the Norwegian Population Register.
2.4. Covariate Assessment
Self-administered question provided information regarding current estrogen therapy, physical
activity, and smoking. Physical activity was categorized as by Vinknes et al. [42]. The sum of the scores
from categorization of light and hard physical activity was calculated. Categories for light physical
activity were 0 (none), 0.25 (<1 h/week), 0.5 (1–2 h/week), or 1.0 (≥3 h/week) and for hard physical
activity were 0 (none), 0.5 (<1 h/week), 1.0 (1–2 h/week), or 2.0 (≥3 h/week). Smoking habits were
categorized as current smoker, former smoker, and never smoked. Measurements of plasma cotinine
were used as a marker of recent nicotine exposure, and participants with cotinine levels ≥85 nmol/L
were defined as smokers [43,44]. The psychical activity score and plasma cotinine were used in the
multivariate models.
2.5. Ethics
HUSK was performed according to the declaration of Helsinki. All participants provided written
informed consent. The Regional Committee for Medical and Health Research Ethics approved the
study protocol (REC number: 2009/825).
2.6. Statistical Analyses
Continuous variables are presented as means and standard deviation and categorical variables as
percentages. Differences in baseline characteristics and dietary intake across sex-specific quartiles were
calculated by linear regression for continuous variables and logistic regression for dichotomous variables.
Fish intake (the exposure variable) was introduced in the analyses (a) in four categories (based on
its sex-specific quartiles) and (b) as a dichotomous variable (comparing the lower quartile, Q1, to the
upper three quartiles Q2 to Q4).
To visually explore the association between fish intake and risk of hip fracture, we used Cox
proportional hazards regression model fitting fish intake using restricted cubic splines with three knots.
Cox proportional hazards regression models with death as competing risk were used to estimate the
risk of hip fractures across fish intake quartiles. The results are presented as hazard ratios (HRs) and
95% confidence interval (CI). Models were adjusted for sex, BMI, plasma concentration of cotinine
≥85 nmol/L, physical activity, and energy intake. Further adjustments for intake of vegetable, fruit,
dairy, or meat, with vitamin D and calcium intake, or estrogen therapy (in women) were made, none
of which changed the strength of the association. In addition to overall analyses, we also conducted
sex-specific analyses. Statistical software SPSS for Windows version 25 (IBM, New York, NY, USA) and
Stata Statistical Software (Release 15.0, College Station, TX, USA: Stata Corp LLC) were used and a
two-sided p-value <0.05 was considered statistically significant.
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3. Results
Out of 3327 eligible participants, information regarding food intake and hip fractures was available
for 2865 (86%).
3.1. Baseline Characteristics and Dietary Intake
Mean (SD) follow-up time was 9.6 years (2.7). Total number of hip fractures was 226 (7.9%), 72
(5.5%) in men and 154 (9.9%) in women. During the study period, 448 men and 305 women died. Death
as first event (without experiencing a hip fracture) was observed in 412 (31.3%) men and 257 (16.6%)
women. Mean (SD) total fish intake as exposure variable of interest was 48 (25) g/1000 kcal in the entire
cohort, with higher consumption in men (51 (25) g/1000 kcal) than in women (45 (25) g/1000 kcal).
Lean fish was the largest fish category consumed, followed by fatty fish, and processed fish, both in
men and women.
Characteristics of the total cohort stratified by sex-specific quartiles of total fish intake at baseline
are presented in Table 1. Both men and women had increasing weight and BMI with higher fish intake.
In women, the femoral neck BMD increased with increasing fish intake, but this was not evident in
men. Self-reported smoking, plasma cotinine levels, and self-reported high alcohol consumption did
not differ across quartiles of fish intake.
Dietary intake of the cohort stratified by sex-specific quartiles of total fish intake at baseline
is presented in Table 2. The energy adjusted protein intake (E %) was significantly higher in high
consumers of fish compared to low consumers, both in men and women. The same was evident for
total vitamin D intake, whereas calcium intake was lower in the high consumers of fish. Although few
participants used fish oil supplements, there were more users of this supplement in high consumers
of fish. A higher proportion of men with high fish consumption used cod liver oil as supplement
compared to the low consumers. Of the food groups consumed, there was an increased intake of
vegetables across quartiles in both men and women. In women, the high consumers of fish had a
higher intake of fruit and berries compared to the low consumers. Compared to participants with low
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3.2. Fish Consumption and the Risk of Hip Fractures
The association of fish intake with hip fracture risk was first explored using fish intake as
sex-specific quartiles with separate estimates for total, lean, and fatty fish. The analysis of total
fish intake as sex-specific quartiles did not reveal any association between fish intake and the risk
of hip fractures, neither in men nor in women (Table 3), nor in the total cohort (data not shown).
This result did not change substantially after multiple adjustments. A competing risk analysis of
mortality and hip fractures was performed; the results did not change materially (data not shown).
A sensitivity analysis was also performed leaving out the non-consumers of lean and fatty fish, but
this did not change the results. Separate analyses for lean and fatty fish showed no associations either
(data not shown).
The analysis was then extended to include a possible non-linear association of fish intake and hip
fracture risk. Low fish intake was associated with higher hip fracture risk although not significantly
(Figure 1). A higher risk of hip fractures was also observed when the lowest quartile of fish intake (Q1)
was compared to higher fish intake (Q2–Q4) (Table 4). This association was, however, only significant
in men. The results remained unchanged after multiple adjustments and competing risk analysis (data
not shown).
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4. Discussion
Our results suggest the existence of a threshold of fish intake below which the risk of hip fracture
appears to increase in older men. This finding is not altered by multiple adjustments and examining
death as a possible competing risk for hip fracture.
4.1. Comparison with Other Studies
Other prospective studies that have investigated the association with fish intake and the risk of
hip fracture did not find significant associations [24,25,45]. A major difference among studies is the
amount of fish consumed. In our study, the fish consumption was high. Participants in the previous
studies would be categorized mainly in the lowest quartile of fish intake in our study [24,25,45].
However, comparison between studies is difficult because other scientists have categorized fish intake
differently [24–26]. The amount of fish consumed in the present study was high enough to allow
analysis of sub-groups of fish intake (lean and fatty fish) separately. However, no association with the
risk of hip fracture was observed in the sub-groups. Other studies have performed sub-group analysis
of fish intake, but the categorization differs. As an example, some studies included shellfish in the fish
category [25,26]. Other differences between the studies include methodological differences in dietary
assessment and adjustment for covariates, and assessment of servings. Another methodological issue
is evaluation of fish intake as part of a general dietary pattern [22,27,28]. In addition to the studies
mentioned above that have been conducted in predominantly Caucasian populations, there are also
studies from Asia [26,46,47]. Asian and Caucasian populations differ genetically, but also in lifestyle
and dietary intake. However, the main conclusion from the studies in Asian populations was that
there is no or only a weak protective association between fish intake and risk of hip fracture.
Assessment of dietary data is challenging, and methodological differences may account for different
findings. Fish intake in most of these studies was assessed using a FFQ [24,25,27,28]. However, in the
European Prospective Investigation into Cancer (EPIC)-study FFQ, diet history, and 24 h recall [22]
were used. In the Japanese cohort [46] a non-specified dietary questionnaire was used. Amounts of
fish in these studies were defined either in servings/week [24,25], times/week or month [45], or above
and below median intake [22,27], as part of a dietary pattern [47], portions/day [28], or not accounted
for [46], which makes any comparison difficult. Moreover, only a few studies reported energy-adjusted
fish intake, and those who did used the energy residual method [25,26,28,45,47].
4.2. Fish and Hip Fracture
When evaluating the risk associated with a single food group, one always has to take into account
the interactions between food groups. High fish consumers had a higher intake of meat, vegetables,
and in women, fruit and berries, and lower intake of dairy. In our study, high fish consumers had
a higher intake of meat and vegetables, and among women, high fish consumers ate more fruit and
berries and less dairy food. Similar results have been reported from a Spanish study that had a
comparable fish intake to our study. Protective effects of high vegetable and fruit consumption have
been reported on the risk of hip fracture [23,48]. For other food groups, there is some uncertainty
regarding an association. This is especially true for dairy products, which is a good source of calcium,
although the association with the risk of hip fracture is uncertain [49]. In the present study, adjustment
for dairy intake did not change the results.
Fish is a good source of n3 PUFAs that have been proposed to be protective [20,25,50,51]. In our
population of Western Norway, the association of fish and PUFA intake may have been modified by
the high frequency of cod liver consumption. In addition to n3 PUFAs, cod liver oil is also a source
of vitamin D. In Norway, it is recommended to those older than 65 years as a vitamin D supplement.
In national surveys, about half of the population followed this advice [52]. However, many older
persons do not consume cod liver oil throughout the year, but information on periods of supplement
use is lacking in HUSK.
Nutrients 2018, 10, 873 10 of 13
Similar to other studies [22,26], we observed a stronger association of fish intake with hip fractures
in men than in women. The association of low intake with increased risk was only significant in
men, which could be due to lower baseline risk in men and a larger variation in fish consumption.
These results may suggest there are other factors aside from fish consumption that are important for
the prevention of hip fracture. In the same population, we previously reported an association between
fish intake and BMD in women [32] whilst investigating fish intake as a continuous variable and in
sex-specific quartiles. However, this did not affect the association of fish intake and hip fractures.
The same was evident for the Framingham Osteoporosis study reporting an association between fish
intake and BMD [53] but not with the risk of hip fracture [25]. In the Cardiovascular Health Study [24],
there was no association between fish intake and either BMD or hip fracture risk.
4.3. Strength and Limitations
The strength of our community-based study is its large sample size with a narrow age range
(70–74 years), a high habitual fish consumption, and a long observation period. The fish intake reported
in our study was similar to intake obtained in the Norwegian dietary survey from 1997 [52] of the
60–79 age group, suggesting that the estimate was valid. The main limitation was that fish intake and
data on potential confounders were only assessed at baseline, and not during the follow-up. However,
dietary habits seldom change rapidly, especially among older persons living at home [54]. Thus, the
intakes reported are likely to represent habits extended throughout a longer period of life.
5. Conclusions
In this large community-based study of men and women with a high habitual fish consumption,
we found a significantly increased risk of hip fracture among men in the lowest quartile compared to
the upper three quartiles of fish intake.
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I dette skjemaet spør vi om dine spisevaner slik de vanligvis er.
Vi er klar over at kostholdet varierer fra dag til dag. Prøv derfor 
så godt du kan å gi et "gjennomsnitt" av dine spisevaner. Ha det
siste året i tankene når du fyller ut skjemaet. Der du er usikker,
anslå svaret.
Skjemaet skal leses av en maskin, og derfor er det viktig at du
setter et tydelig kryss i avmerket rute.
Riktig markering er slik:
Bruk helst bløt blyant. Feil kan da rettes med viskelær.
Kulepenn og svart tusjpenn kan også brukes.
Av hensyn til den maskinelle lesingen pass på at arkene ikke blir brettet.
Alle svar vil bli behandlet strengt fortrolig.
EKSEMPEL PÅ UTFYLLING AV SPØRSMÅL 1.
Kari Nordmann spiser daglig 5 skiver brød og ett
knekkebrød. Hun spiser vanligvis kneippbrød, men i helgene
blir det en del loff. I tillegg spiser hun ett knekkebrød hver
dag. Hun fyller ut første spørsmål slik:
1.HVOR MYE BRØD PLEIER DU Å SPISE?
Legg sammen det du bruker til alle måltider i løpet av en dag.
(1/2 rundstykke = 1 skive, 1 baguett = 5 skiver, 1 ciabatta = 4 skiver)
Fint brød
(loff, baguetter, fine rundstykker o.l.)
Mellomgrovt brød
(lys helkorn, lys kneipp, lyst hj.bakt o.l.)
Grovt brød
(fiberkneipp, mørk kneipp, mørkt hj.bakt o.l.)
Knekkebrød
(kavring, grov skonrok o.l.)
0 1/2 1 2 3 4 5 6 7 8 9 10 11 12+
Antall skiver pr. dag
Sum skiver pr. dag = ____
Antall skiver pr. uke: _______ = ____  Tallet brukes i spørsmål 5.
6
6 x 7 42
2.HVA PLEIER DU Å SMØRE PÅ 
BRØDET?
Merk av både for hverdag og helg, selv
om du bruker det samme.
3.OM DU BRUKER 
FETT PÅ BRØD, HVOR
MYE BRUKER DU?
4.MELK SOM DRIKK
(1 glass = 1,5 dl)
1.HVOR MYE BRØD PLEIER DU Å SPISE?
Legg sammen det du bruker til alle måltider i løpet av en dag.
(1/2 rundstykke = 1 skive, 1 baguett = 5 skiver, 1 ciabatta = 4 skiver)
Fint brød
(loff, baguetter, fine rundstykker o.l.)
Mellomgrovt brød
(lys helkorn, lys kneipp, lyst hj.bakt o.l.)
Grovt brød
(fiberkneipp, mørk kneipp, mørkt hj.bakt o.l.)
Knekkebrød
(kavring, grov skonrok o.l.)
0 1/2 1 2 3 4 5 6 7 8 9 10 11 12+
Antall skiver pr. dag
Sum skiver pr. dag = ____
Antall skiver pr. uke: ____ x 7 = ____. Tallet brukes i spørsmål 5.
Hverdager Lørdager, søndager En porsjonspakning på 12 g
rekker til antall skiver
Bruker ikke












Smør   (meierismør)
Bremykt, Smøregod
Brelett












Skummet melk, søt, sur
61852
5.PÅLEGGSSORTER
Bruk sum skiver pr. uke fra spørsmål 1.
Brun ost, prim
Hvit ost, helfet, 27% fett (Jarlsberg,
Norvegia o.l., smøreost; eske, tube)
Hvit ost, halvfet, 16% fett (Jarlsberg,
Norvegia o.l., smøreost; eske, tube)










Sardiner, sursild, ansjos o.l.









Frukt som pålegg (banan, eple o.l.)
Salater med majones
(kokt, stekt, eggerøre, omelett)
6.EGG
0
Til antall skiver pr. uke
1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+





8. KAFFE OG TE
(1 kopp kaffe = 1,2 dl    1 kopp te = 2 dl)
7. FROKOSTGRYN, GRØT OG YOGHURT
Svar enten pr. måned eller pr. uke. <1 betyr sjeldnere enn 1 gang.
Melk søt, sur på gryn,
grøt og dessert
Havregryn, kornblandinger


















Kunstig søtstoff til kaffe eller te
0 1/2 1 2 3
Antall teskjeer eller biter pr. kopp
4+
1/2 1 3-42 5-6






Gang pr. måned Gang pr. uke Mengde pr. gang
4-5 6-7 8+1321<10
1 1 1/2 2 3+
1 1 1/2 2 3+
1-2 3-4 5-6 7+
1 2 3-4 5+
1/2 1 1 1/2 2+
1/2 1 1 1/2 2+
1/2 1 1 1/2 2+














Kjøttdeigretter (saus eller gryte
med kjøttdeig, lasagne o.l.)
9. ANDRE DRIKKER?
Svar enten pr. måned eller pr. uke.  < 1 betyr sjeldnere enn 1 gang.
Merk at porsjonsenhetene er forskjellige. 1/3 liter tilsvarer en halvflaske øl 
og 2/3 liter tilsvarer en helflaske.
Vann
Appelsinjuice




Brus, Cola, Solo o.l.,
med sukker
Brus, Cola, Solo o.l.,
kunstig søtet






















Gang pr. måned Gang pr. uke Mengde pr. gang














1/2 1 2 3 4
1/2 1 2 3 4
1/2 1 2 3 4
1/2 1 2 3 4
1/2 1 2 3 4
1/4 1/3 1/2 2/3 1
1/4 1/3 1/2 2/3 1
1/4 1/3 1/2 2/3 1
1/4 1/3 1/2 2/3 1
1/4 1/3 1/2 2/3 1
1 2 3 4 5















Vi spør både om middagsmåltidene og det du spiser til andre måltider. Tell til slutt
sammen antall retter du har merket for og se om summen virker sannsynlig.
En "dl" tilsvarer omtrent mengden i en suppeøse. Med "ss" menes en spiseskje.
Mengde pr. gang
1/2 2/3 1 2+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+





Koteletter (lam, okse, svin)
Biff (alle typer kjøtt)
Stek (elg, hjort, reinsdyr o.l.)
Stek (lam, okse, svin)











Torsk, sei, hyse (stekt, panert)
Sild (fersk, speket, røkt)
Makrell (fersk, røkt)















































1<10 3 4 5-6 7-8 9+
1/8 1/4 1/2 3/4 1+
21<10 3 4 5-6 7-8 9+
21<10 3 4 5-6 7-8 9+
21<10 3 4 5-6 7-8 9+
1/2 1 1 1/2 2 2 1/2+
1-2 3-4 5-6 7-8 9+
1/4 1/3 1/2 3/4 1+
1 2 3 4 5+
1/2 1 1 1/2 2 3+
1-2 3-4 5-6 7-8 9+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1/2 1 1 1/2 2 2 1/2+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-9 10+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1/2 1 1 1/2 2 2 1/2+
7
61852
11. POTETER, RIS, SPAGHETTI, GRØNNSAKER
Svar enten pr. måned eller pr. uke. <1 betyr sjeldnere enn 1 gang.
Disse spørsmålene dreier seg først og fremst om tilbehør til middagsretter, men
spiser du for eksempel en rå gulrot eller salat til lunsj, skal det tas med her. 
0
Gang pr. måned Gang pr. uke Mengde pr. gang





























Hvor mange ganger om dagen spiser du vanligvis

























1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1/2 1 2 3 4+
1/2 1 2 3 4+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1/2 1 1 1/2 2 3+
1/4 1/2 3/4 1 1 1/4 +
1/2 1 1 1/2 2 3+
0 1 2 3 4 5+
8
61852
12. TYPE FETT TIL MATLAGING
13. FRUKT
Svar enten pr. måned eller pr. uke. < 1 betyr sjeldnere enn 1 gang.
Hvor mange frukter spiser du vanligvis pr. dag?





























Gang pr. måned Gang pr. uke









1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
Multer (dl)
1/2 1 2 3+
7 8 9+
61852
14. DESSERT, KAKER, GODTERI














(Cookies, Bixit, Hob Nobs)
Sjokolade (60 g)
Drops, lakris, seigmenn o.l.
Smågodt (1 hg = 100g)
Potetgull (1 pose 100g = 7 dl)
Annen snacks (skruer, crisp,
saltstenger, lettsnacks o.l.)
Peanøtter, andre nøtter
(1 pose 100g = 4 never)
Gang pr. måned Gang pr. uke Mengde pr. gang




























































Hvis annet, hvilket? ..................................................................
Hvis annet, hvilket? ..................................................................





























1 ts 1 bs 1 ss
1 2+
1-2 3-4 5-6 7+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+







16. NÅR SPISER DU PÅ HVERDAGER?
17. MENER DU SVARENE I SPØRRESKJEMAET GIR
ET BRUKBART BILDE AV KOSTHOLDET DITT?
18. ER DU FORNØYD MED KROPPSVEKTEN DIN SLIK DEN ER NÅ?
19. KJØNN
Vennligst se etter at du har svart på alle spørsmål.
Takk for innsatsen!
HOVEDMÅLTIDER som frokost, formiddagsmat, middag, kvelds.
MELLOMMÅLTIDER som kaffe, frukt, godteri, snacks m.v.
Er det matvarer/produkter du regelmessig bruker, og som ikke er nevnt i skjemaet?
.................................................................................................................................
.................................................................................................................................
6 8 10 12 14 16 18 20 22 24 2 4
6 8 10 12 14 16 18 20 22 24 2 4
Ja Nei
Ja
Nei, jeg ønsker å slanke meg
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